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General introduction and 





















"The philosophies of one age have become the absurdities of the next, 






The discovery of the anatomy and function of the right ventricle cannot be 
attributed to a single person nor to a single era. Over the centuries many 
erroneous ideas have been replaced with other, not necessarily correct, ideas. 
Religion and superstition dominated daily life for millennia and greatly influenced 
the perspective on the function of the heart and vessels. Moreover, many 
physicians were above all things theologians. 
 
Ancient Greece 
The first thorough description of right ventricular anatomy can be found in the 
Hippocratic Corpus, over 70 books written by Hippocrates (460-375 B.C.) and 
followers [1]. “The heart is an exceedingly strong muscle, ‘muscle’ in the sense not 
of ‘tendon’ but of a compressed mass of flesh. It contains in one circumference 
two separate cavities, one here, the other there. These cavities are quite 
dissimilar: the one on the right side lies face downwards, fitting closely against the 
other. By ‘right’ I mean of course the right of the left side, since it is on the left side 
that the whole heart has its seat. Furthermore this chamber is very spacious, and 
much more hollow than the other. It does not extend to the extremity of the 
heart, but leaves the apex solid, being as it were stitched on outside. The inside 
surface of both chambers is rough, as though slightly corroded; the left more so 
than the right” 
  
The doctrine of Galen 
Galen (131-201 A.D.), a brilliant physician, proved arteries contained blood and 
made a coherent concept of human physiology based on dissecting animals. He 
connected and integrated the vital functions of nutrition and respiration with the 
function of blood and the nervous system. As he was not aware of the presence of 
the circulation as we know it now, his description of the heart and vessel 
comprised two open-ended systems which provided one-time distribution of 
nutrients to the tissues. Absorbed food was made into blood containing ‘nutritive 
spirits’ by the liver. Veins, which all had their origin in the liver, distributed these 
‘nutritive spirits’ throughout the entire body. He imagined the blood in the veins 
moved back and forth like tides of the sea. Part of the ‘nutritive spirits’ passed 
through invisible pores in the interventricular septum from the right to the left 
ventricle where it was mixed with air to form ‘vital spirits’. ‘Vital spirits’, necessary 
for sustaining life and heat, were distributed by arteries. None of the blood 

































absorbed as nutrition by the lungs. So there was no separate systemic and 
pulmonary circulation in which arteries and veins were connected. Galen’s theory 
on human physiology dominated Western medicine for fourteen centuries as he 
was seen as a divine man, the father of physicians. Furthermore, his theory was 
coherent and represented churchly doctrine. 
 
Discovery of the circulation  
At the end of the Middle Ages dissection of humans to study human anatomy and 
physiology was started once more and some physicians started questioning the 
authority of Galen. Michael Servatus (1511-1553) is considered the first to 
describe and publish the concept of the pulmonary circulation [2]. In fact he was 
the first European physician as three centuries before the pulmonary circulation 
was described by the Arab physician Ibn-an-Nafas [3]. His view on the pulmonary 
circulation was neglected and forgotten probably due to its heretical and original 
character. Michael Servatus described the pulmonary circulation in De 
Christianismi Restitutio. This was originally a theology work which intention was to 
prove the existence of the soul inside the blood [2]. “It (vital spirit) is a subtle 
spirit, generated by the power of heat, of yellow color and possessor of the power 
of the fire, so as to become a sort of lucid vapor of the purified blood, enclosing 
the elements of the water, the air and the fire. It is instantly produced inside the 
lungs by a mixture of inhaled air and subtle blood, while it is elaborated and 
communicated from the heart’s right ventricle to the left one. This communication 
is not mediated via the median septum of the heart, as it is habitually thought; on 
the contrary, the subtle blood is transferred from the right ventricle, in a brilliant 
way, by following a long circuit through the lungs, which submits it into a 
transformation, in order for the blood to come out colored yellow: the arterial vein 
[pulmonary artery] transports it into the venous artery [pulmonary vein]. From 
that moment on, the blood is mixed in that very same venous artery with the 
inhaled air in order to become re-purified from all fuliginous materials, during this 
expiration. In this way, the entirety of this mixture is finally attracted by the left 
ventricle of the heart, during the diastole, to serve as a base for the vital spirit.” De 
Christianismi Restitutio was the reason for condemning him to be burned at the 
stakes because it also preached nontrinitarianism and anti-infant baptism. Even in 
his last words he defied the inquisitor: “Oh Jesus, son of eternal God, have pity on 
me” [2].  
        Finally, William Harvey (1578-1657) explained the circulation and presented 
the determinant proofs in his thesis, De Motu Cordis, which established the 
foundation for the understanding of the systemic and pulmonary circulation [4]. 
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He described the importance of right ventricular function: “Thus the right ventricle 
may be said to be made for the sake of transmitting blood through the lungs, not 
for nourishing them.” He knew his message would be controversial: “What 
remains to be said on the quantity and source of this transferred blood, is, even if 
carefully reflected upon, so strange and undreamed of, that not only do I fear 
danger to myself from the malice of a few, but I dread lest I have all men as 
enemies, so much does habit or doctrine (referring to Galen’s doctrine) once 
absorbed, driving deeply its roots, become second nature, and so much does 
reverence for antiquity influence all men. But now the die is cast, my hope is in the 
love of truth and in the integrity of intelligence.” The discovery of the circulation 
was received with great interest and accepted almost at once in his home country, 
England. On the mainland of Europe it won favor more slowly, however, before his 
death his concept was acknowledged by the medical profession [5].  
        Harvey’s followers have progressively completed the knowledge of 
cardiovascular physiology. However, up to the first half of the twentieth century 
there was almost no interest in the right ventricle. The main reason was the right 
ventricle was considered little more than a conduit for blood flow between the 
venous circulation and the pulmonary circulation [6]. Furthermore, how were they 
to investigate the right ventricle when there were almost no non-invasive tools to 
measure right ventricular function and volumes? This all changed with the 



































Anatomy and physiology 
 
Septa divide the heart in a right- and left-sided compartment. The anulus fibrosus, 
a structure of dense connective tissue, subdivides each half of the heart into two 
cavities, the upper part being called atrium, the lower part ventricle. The 
morphology and structure of the right and left ventricle is substantially different as 
a result of the difference in origin of myocardial precursor cells and the vascular 
resistance of the pulmonary and systemic circulation [7,8]. Compared to the 
systemic circulation, the lungs are close to the heart and the pulmonary arteries 
and veins are relatively short and broad. This results in a low vascular resistance 
which can be easily overcome with a small increase in right ventricular pressure.  
        Compared to the left ventricle, the right ventricle has a complex geometry, 
with a triangular shape in the sagittal plane and a crescent shape in the coronal 
plane. The shape of a normal right ventricle can be imagined as a thin pouch that is 
wrapped around the thick ellipsoid left ventricle. Right ventricular mass is only one 
sixth of left ventricular mass. Functionally, the right ventricle can be divided into 
an inlet, outlet and apical coarsely trabeculated component. The inlet component 
consists of the tricuspid valve which is connected to its subvalvular apparatus. The 
subvalvular apparatus, comprising chordae tendineae and papillary muscles, 
prevents valve leaflets prolapsing into the atrium during ventricular contraction. 
The smooth walled muscular outlet, is separated from the inlet by a thick muscle, 
the crista supraventricularis, which arches from the anterolateral wall over the 
anterior leaflet of the tricuspid valve to the septal wall. At the lower septal 
segment of the crista supraventricularis, the septomarginal band originates and 
becomes continuous with the moderator band, which attaches to the lateral free 
wall and apex of the right ventricle [7]. 
        Although the right ventricle is normally located on the right side of the heart 
and connected with the pulmonary circulation, this is not always the case in 
complex congenital heart disease. Several anatomic structures are distinctive 
features of the morphological right ventricle which can help differentiate the right 
from the left ventricle when imaging the heart. The right-sided atrioventricular 
valve has a trileaflet configuration with septal chordal and papillary insertions and 
a more apical hinge line of the septal leaflet relative to the anterior leaflet of the 
left-sided atrioventricular (mitral) valve. The right ventricular outflow tract is 
muscular and has no fibrous continuity with the atrioventricular valve. The apical 
trabeculae are much more coarsely than that of the left ventricle and the right 
ventricle has a moderator band [7].  
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Congenital heart disease 
 
The emergence of cardiac surgery and advances in pediatric care dramatically 
increased the number of patients with complex congenital heart disease that 
survived into adulthood. Currently, the number of adults with complex congenital 
heart disease outnumber that of children [9]. In many patients with ‘corrected’ 
congenital heart disease the right ventricle has to perform under abnormal 
circumstances such as pressure or volume overload. The importance of the right 
ventricle became apparent after many of these patients developed short- and 
long- term complications. The normal healthy right ventricle performs under low 
pressures and is very compliant. The longitudinal orientation of most muscle fibers 
in the right ventricle results in a peristaltic contraction pattern that works as a 
bellows by pumping the blood against the interventricular septum towards the 
pulmonary artery. Although this mechanism generates low pressures, it is very 
efficient and can handle large changes in blood volume [7,8]. As the right and left 
ventricle share multiple muscle fibres, have a common interventricular septum 
and are constrained in the pericardial sac, both ventricles interact. In the normal 
heart, left ventricular contraction substantially contributes to rise in right 
ventricular pressure. Remodeling of the right ventricle in response to longstanding 
volume or pressure overload helps maintaining normal levels of cardiac output for 
a long period of time. Remodeling of the right ventricle involves a change in 
geometry of both ventricles with a progressively reduced diastolic left ventricular 
volume due to septal displacement and paradoxical systolic septal movement. This 
remodeling is detrimental for left ventricular output, especially during exercise 
[7,8]. Furthermore, in adulthood complications such as overt failure of the right 
ventricle, arrhythmias and sudden death often occur. Therefore, improving care in 
adult patients with congenital heart disease has in recent years focused on 
prevention of complications. Imaging of the right ventricle is indispensable in this 
setting. For example, most patients with ‘repaired’ tetralogy of Fallot have a 
volume overloaded right ventricle due to longstanding pulmonary regurgitation. 
This has been related to right ventricular dilation, right ventricular dysfunction, 
reduced left ventricular volumes, symptomatic heart failure, ventricular 
arrhythmia and sudden death [10-12]. Measurements of right and left ventricular 
volumes can guide timing of pulmonary valve replacement to relieve the volume 






































Evaluation of right ventricular volumes and function is considered one of the 
cornerstones in the management of patients with ‘repaired’ congenital heart 
disease [10,11]. The right ventricle can be imaged with chest radiography, contrast 
angiography, radionuclide studies, computed tomography, echocardiography and 
cardiac magnetic resonance imaging. Preferably, imaging of right ventricular 
anatomy, volume and function is cheap, readily available, safe, accurate and 
reproducible. For serial measurements of the right ventricle during follow-up, 
imaging modalities that are invasive or use radiation are considered inappropriate. 
Therefore, echocardiography and cardiac magnetic resonance imaging are most 
frequently used in clinical practice [11].  
        The first modality to image the heart without radiation exposure was 
ultrasound. Although the existence of ultrasound was already recognized in bats in 
the 18
th
 century, the development of cardiac ultrasound had to wait till the 
development of piezo-electric quartz crystals. In the 1950s, the first cardiac 
ultrasound was performed [18]. In the 1960s, progress was made in real-time two-
dimensional echocardiography and now even three-dimensional ultrasound is 
available. Currently, two-dimensional echocardiography is the most frequently 
used modality to study the right ventricle as it is relatively cheap and readily 
available [19]. It excels in real-time visualization of small and mobile structures like 
valves. Since the heart is located in an angle with respect to the longitudinal axis of 
the body and is rotated slightly to the left, the ventral part of the heart consists 
mainly of right atrium and right ventricle. Although cardiac morphology can be 
visualized, this retrosternal position of the right ventricle limits echocardiographic 
visualization. Furthermore, the complex geometry of the right ventricle hampers 
reliable translation from two-dimensional diameters to volumes resulting in 
inaccurate measurements of right ventricular volume and function [20].   
        In 1946, the phenomenon of magnetic resonance was discovered which led to 
the development of nuclear magnetic resonance imaging [21,22]. Attenuation of 
tissues depends on the behavior of tissues when placed in an external magnetic 
field and exposed to radiofrequency radiation. In 1977, the first horizontal image 
through the human thorax was made, however, the acquisition time was to long to 
generate a qualitative good image of the heart [23]. With the introduction of ECG 
gating derived from nuclear radiology the first good quality cardiac images of the 
heart were generated in 1983. Nowadays, cardiac magnetic resonance is 
considered the gold standard for evaluation of cardiac volumes and function [24]. 
It is a cross-sectional technique that has the advantage of unrestricted fields of 
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view. Furthermore, with the newest sequences contrast between blood and 
muscle is outstanding. Measurements of right ventricular volumes and function do 
not rely on assumptions of geometry but uses slice summation to calculate 
volumes, which are highly accurate and reproducible. However, gold standard is 
not a synonym for perfect. The complex anatomy and morphology of the right 
ventricle result in less accurate and reproducible measurements compared to left 
ventricular measurements. Analyzing cardiac magnetic resonance derived images 
of the heart requires post-processing with extensive manual contouring, which is 
operator-dependent. Furthermore, part of the differences in right ventricular 
volumes and function reported in literature are the result of a difference in 
methodology and patient characteristics [24-26]. Therefore, interpretation and 
application of literature in clinical practice requires information to what extent 


































Outline of the thesis 
 
This thesis discusses imaging of the right ventricle in patients with congenital heart 
disease. 
        In many centers the right ventricular end-systolic and end-diastolic frame is 
selected independently from the left ventricular end-systolic and end-diastolic 
frame. Others state that independent selection of the right ventricular frame is 
unnecessary as the magnitude of the misrepresentation of right ventricular 
volumes and function is too small to be of clinical importance. In Chapter 2 the 
magnitude of this misrepresentation is assessed. 
        An issue in post-processing is whether to consider trabeculae and papillary 
muscles part of measured right ventricular volumes or mass. Including 
trabeculations in the right ventricular blood volume makes analysis faster and 
more reproducible compared to excluding these trabeculations manually, 
however, right ventricular volumes will be overestimated. In Chapters 3, 4 and 5 
this issue is addressed. Chapter 3 validates a novel segmentation algorithm which 
semi-automatically excludes trabeculations and papillary muscles. Chapter 4 
studies the impact of right ventricular trabeculations and papillary muscles on 
measured right ventricular volumes and function in patients with repaired 
tetralogy of Fallot. Chapter 5 shows the impact of right ventricular trabeculations 
and papillary muscles on measured volumes and function in patients with pressure 
overloaded right ventricles.  
        Chapter 6 evaluates the effects of right ventricular outflow tract obstruction 
on exercise capacity, right ventricular volumes, function and mass in adult patients 
with tetralogy of Fallot and volume overload due to pulmonary regurgitation. 
Recent studies demonstrated that patients with tetralogy of Fallot and combined 
pulmonary regurgitation and right ventricular outflow tract obstruction have 
smaller right ventricular volumes and higher ejection fraction compared to 
patients with isolated pulmonary regurgitation, however, the effect on exercise 
capacity is unknown.  
        Chapter 7 describes the study design and rationale of the ‘Functional outcome 
and quality of life in adult patients with congenital heart disease and prosthetic 
valves (PROSTAVA) study’. Purpose of this prospective study is to describe the 
relation between prosthetic valve characteristics in adult patients with congenital 
heart disease on one hand and functional outcome, quality of life, the prevalence 
and predictors of prosthesis-related complications on the other hand. An 
addendum was added on measurements of right ventricular volumes and function 
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Objectives: To investigate to what extent cardiovascular MRI derived 
measurements of right ventricular (RV) volumes using the left ventricular (LV) end-
systolic and end-diastolic frame misrepresent RV end-systolic and end-diastolic 
volumes in patients with tetralogy of Fallot (ToF) and a right bundle branch block. 
 
Methods: Sixty-five cardiac MRI scans of patients with ToF and a right bundle 
branch block, and 50 cardiac MRI scans of control subjects were analyzed. RV 
volumes and function using the end-systolic and end-diastolic frame of the RV 
were compared to using the end-systolic and end-diastolic frame of the LV.  
 
Results: Timing of the RV end-systolic frame was delayed compared to the LV end-
systolic frame in 94% of patients with ToF and in 50% of control subjects. RV end-
systolic volume using the RV end-systolic instead of LV end-systolic frame was 
smaller in ToF (median -3.3 ml/m
2
, interquartile range -1.9 to -5.6 ml/m
2
; p < 
0.001) and close to unchanged in control subjects. Using the RV end-systolic and 
end-diastolic frame hardly affected RV end-diastolic volumes, while increasing the 
ejection fraction from 45 ± 7% to 48 ± 7% for patients with ToF (p < 0.001) rather 
than control subjects (54 ± 4%, both methods). QRS duration correlated positively 
with the changes in the RV end-systolic volume (p < 0.001) and RV ejection fraction 
obtained in ToF patients when using the RV instead of the LV end-systolic and end-
diastolic frame (p = 0.004). 
 
Conclusion: For clinical decision making in ToF patients RV volumes derived from 








Evaluation of right ventricular (RV) volumes and function is crucial in the 
management of patients with congenital heart disease [1,2]. RV dysfunction is 
particularly a problem in patients with tetralogy of Fallot (ToF) due to longstanding 
massive pulmonary regurgitation. Irreversible RV dysfunction can be prevented by 
pulmonary valve replacement before a certain threshold value for RV end-systolic 
and end-diastolic volume is reached [3-7]. Cardiac magnetic resonance (CMR) 
imaging is the golden standard in the evaluation of RV volume and function, and 
plays an important role in the decision for pulmonary valve replacement in 
patients with ToF and pulmonary regurgitation [1-7]. 
        To acquire accurate CMR derived volume measurements, correct selection of 
the RV end-systolic and end-diastolic frame may be important. In normal hearts, 
contraction of the RV lags slightly behind that of the left ventricle (LV) [8]. Most 
patients with ToF have a right bundle branch block (RBBB) which leads to intra- 
and interventricular dyssynchrony. This dyssynchrony significantly extends 
duration of RV contraction and delays timing of RV end-systole compared to the LV 
[7,9,10]. Additionally, timing of RV ejection and end-diastole may be delayed in 
patients with ToF [11,12]. In many centers the RV end-systolic and end-diastolic 
frame is selected independently from the LV end-systolic and end-diastolic frame 
[13,14]. However, the magnitude of the overestimation of RV end-systolic volume 
and underestimation of RV end-diastolic volume and ejection fraction is unknown. 
Therefore, others state that independent selection of the RV frame is unnecessary 
as the magnitude of the misrepresentation of RV volumes and function is too small 
to be of clinical importance. 
        The present study is the first to quantitatively document the influence of 
independent selection of the end-systolic and end-diastolic frame for the RV and 





























Materials and methods 
 
Study population 
Our institution’s CMR database was searched to collect 65 of the most recent CMR 
scans of patients with ToF and 50 normal CMR scans performed in patients 
suspected for myocardial infarction (control subjects). Normal CMR scans were 
defined as normal anatomy, normal LV and RV contraction, normal LV and RV 
volumes and ejection fraction with no signs of infarction, and no valvular 
dysfunction [15]. Ischemia was ruled out by stress testing. In all patients 
electrocardiograms performed within 6 months to the CMR date were collected to 
evaluate rhythm and conductance disturbances. A RBBB was present when the 
longest manually measured QRS duration ≥ 100 ms in combination with a terminal 
R wave in lead V1 and V2, wide S wave in I and V6 on the electrocardiogram [16]. 
        RBBB is defined as complete when the QRS duration ≥ 120 ms and defined as 
incomplete when the QRS duration is ≥100 ms and <120 ms [16]. CMR scans of 
patients with ToF were included when RBBB was the only conductance delay and 
no additional conductance delays were present. CMR scans of control subjects 
were excluded when conductance delays were present on the electrocardiogram 
[16]. 
        This retrospective study was approved by the University Medical Center 
Groningen review board. Informed consent was not required according to the 
Dutch Medical Research Involving Human Subjects act. 
 
Cardiac magnetic resonance imaging: 
All subjects were examined on a 1.5-Tesla MRI system (Siemens Magnetom 
Sonata, Erlangen, Germany or Siemens Magnetom Avanto, Erlangen, Germany) 
using a 2 x 6 channel body-coil. After single-shot localizer images, for function 
analysis short axis cine loop images with breath holding in expiration were 
acquired using a retrospectively gated balanced steady state free precession 
sequence. Short axis slices were planned in end-diastole from two slices above the 
mitral valve plane to the apex. The following parameters were used: TR 2.7 ms, TE 
1.1 ms, flip angle 80
o
, field of view 320 mm, matrix 192 x 192 mm, 25 frames per 
cycle, slice thickness 6 mm, interslice gap 4 mm, voxel size 1.7 x 1.7 x 6 mm.  
        Image analysis was performed using commercially available software (QMass 
version 7.2., Medis, Leiden, The Netherlands). The end-systolic and end-diastolic 
frame was defined as the frame with the smallest and largest volume, 
respectively.These frames were selected by visual assessment independently for 
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the LV and RV. LV and RV contours were drawn manually by tracing the 
endocardial borders in every slice in the end-systolic and end-diastolic frame of 
the LV. Contour tracing was aided by reviewing the multiple phase scans in the 
movie mode. The papillary muscle and trabeculae were considered part of the 
cavum. Additionally, RV contours were drawn in the end-systolic and end-diastolic 
frame of the RV.  
        The basal slice was selected with aid of long-axis cine view images. The basal 
slice of the LV was defined as the most basal slice surrounded for at least 50% by 
the LV myocardium. When the pulmonary valve was visible in the RV basal slice, 
only the portion of the right ventricular outflow tract below the level of the 
pulmonary valve was included. For the inflow part of the RV, the blood volume 
was included when the ventricle wall was trabeculated and thick compared to the 
right atrium wall [15]. 
        Stroke volume was defined as end-diastolic volume minus end-systolic 




RV contours were first drawn in the visually selected end-systolic and end-diastolic 
frame of the RV. To minimize intraobserver variability, RV contours drawn in the 
end-systolic and end-diastolic frame of the RV were copied to the LV end-systolic 
and end-diastolic frame and then adjusted to this frame.  
        To obtain intra- and interobserver reproducibility, contours were drawn 
independently twice by the first observer and once by the second observer in 25 
scans of patients with ToF and 25 scans of control subjects. The end-systolic and 
end-diastolic frame was selected independently twice by the first observer and 
once by the second observer. There were at least two weeks between repeated 
contour drawing by the first observer. Both observers had more than 2 years 
experience with RV contour drawing. 
 
Statistical analyses 
Descriptive statistics were calculated for all measurements as mean and standard 
deviation for normally distributed continuous variables, median with interquartile 
range (IQR) for skewed continuous variables and absolute numbers and 
percentages for dichotomous variables. Reproducibility was evaluated with the 
intraclass correlation coefficient (ICC). For normally distributed continuous 
variables a paired-samples Student’s t-test and for skewed continuous variables a 



























and end-diastolic frame with RV volumes measured in the RV end-systolic and end-
diastolic frame. For normally distributed continuous variables an independent 
Student’s T-test and for skewed continuous variables a Mann-Whitney test was 
used to compare the difference in RV volumes between normal scans and scans of 
patients with ToF when measuring RV volumes in the end-systolic and end-
diastolic frame of the RV instead of the LV. The relation between QRS duration and 
change in RV volume and function when using the end-systolic and end-diastolic 
frame of the RV instead of the LV was analyzed using linear regression. The 
Statistical Package for the Social Sciences version 16.0 (SPSS Inc, Chicago, IL) was 
used for all statistical analyses. All statistical tests are two-sided and a P-value of 






Between January 2008 and January 2011, 65 CMR scans of patients with ToF (50 
with complete RBBB, 15 with incomplete RBBB) and 50 normal CMR scans of 
control subjects were collected. Patients with ToF (37 male, 28 female; median age 
28 years, IQR 21 to 37 years) were younger than control subjects (33 male, 17 
female; median age 56 years, IQR 41 to 65 years), p < 0.001. QRS duration was 
longer in patients with ToF (145 ± 25 ms) than in control subjects (93 ± 9 ms), p < 
0.001. Heart rate during the CMR scan was similar in patients with ToF (70 ± 12 
bpm) and control subjects (73 ± 15 bpm), p = NS. 
 
Timing of end-systole and end-diastole 
The difference in frame selection of end-systole and end-diastole between the RV 
and LV is shown in table 1. 
 
 
Table 1. End-systolic and end-diastolic frame selection of the RV compared to the LV. 
RV – LV frame 
End-systole  End-diastole  
ToF Control  ToF Control  
RV 3 frames earlier 0 (0) 0 (0)  2 (3) 0 (0)  
RV 2 frames earlier 0 (0) 0 (0)  2 (3) 2 (4)  
RV 1 frame earlier 0 (0) 0 (0)  14 (22) 14 (28)  
No difference 4 (6) 25 (50)  38 (58) 34 (64)  
RV 1 frame later 26 (40) 25 (50)  8 (12) 0 (0)  
RV 2 frames later 28 (43) 0 (0)  0 (0) 0 (0)  
RV 3 frames later 7 (11) 0 (0)  1 (2) 0 (0)  
Data are expressed as number of patients (%). LV = left ventricle, RV = right ventricle, ToF = 
tetralogy of Fallot 
 
 
Figure 1 shows the time-volume curve of the RV and LV of a patient with ToF and a 
complete RBBB. In almost all patients with ToF and half of control subjects the 
end-systolic frame of the RV was delayed compared to the LV. The resulting 
median difference in timing between the end-systolic frame of the RV and LV was 
larger in patients with ToF (median -53 ms, IQR -73 to -37 ms) than in control 
subjects (median -11 ms, IQR -32 to 0 ms), p < 0.001. Timing of the end-diastolic 
frame was not different between the RV and LV in most patients with ToF and 



























frame of the RV and LV frame was similar in patients with ToF (median 0 ms, IQR 0 
to 36 ms) and control subjects (median 0 ms, IQR 0 to 32 ms), p = NS. 
 
 
Figure 1. Example of the LV and RV end-
systolic frame and the corresponding 
time-volume      curve. Two short axis 
images of the end-systolic frame of the 
LV (upper left) and RV (upper right), and 
the corresponding time-volume curve 
(below) in a patient with ToF and a 
complete RBBB. Timing of the  RV end-
systolic frame is 106 ms (3 frames) 
delayed compared to LV end-systolic   
frame. Measuring the RV end-systolic 
volume in the LV instead of the RV end-
systolic frame results in a difference of 9 
ml/m2. This is visible in the short-axis 
image of the RV end-systolic frame 
(upper right) in which the larger blue 
contour corresponds to the RV contour 
of the LV end-systolic frame (upper left) 
and the yellow contour to the RV contour 
of the RV end-systolic frame. Timing of 
the end-diastolic frame is the same for 
the RV and LV. 
 
 
Change in RV volume and function 
Table 2 shows RV volumes and function measured in the end-systolic and end-
diastolic frame of the LV and RV.  Using the RV end-systolic instead of LV end-
systolic frame in patients with ToF, mean RV end-systolic volume was reduced 
from 78 to 74 ml/m
2
 (p < 0.001) while ejection fraction and stroke volume grew 
from 45 to 48% (p < 0.001) and from 62 to 66 ml/m
2
, respectively (p < 0.001). ToF 
patient’s changes in RV end-diastolic volume and the changes in any of these four 
parameters in the controls were very small, though still significant in paired data 
analysis. Figure 2 shows the difference in volumes and function when using the 
end-systolic and end-diastolic frame of the RV instead of the LV. The decrease in 
RV end-systolic volume was incremental when going from controls to patients with 
ToF and an incomplete RBBB to patients with ToF and a complete RBBB (p<0.001). 
In patients with ToF linear regression showed a significant association between 




0.190, p < 0.001), and RV ejection fraction (B 4.25, CI 1.40 – 7.10, R
2
 = 0.124, p = 




Table 2. RV volumes measured in the end-systolic and end-diastolic frame of the LV and RV. 
 LV frame RV frame RV frame – LV frame P 
ToF     
     RV ESV (ml/m
2
) 77.8 ± 24.1 73.6 ± 23.0 -3.3 (-5.6 to -1.9) <.001 
     RV EDV (ml/m
2
) 139.6 ± 35.0 140.0 ± 35.0 0.0 (0.0 to 0.9) <.001 
     RV EF (%) 44.8 ± 7.4 48.0 ± 6.9 2.8 (1.8 to 4.6) <.001 
     RV SV (ml/m
2
) 61.8 ± 16.4 66.4 ± 16.7 4.1 (2.6 to 5.8) <.001 
Control subjects     
     RV ESV (ml/m
2
) 35.1 ± 7.6 34.9 ± 7.6 0.0 (-0.4 to 0.0) .003 
     RV EDV (ml/m
2
) 75.2 ± 12.4 75.4 ± 12.3 0.0 (0.0 to 0.1) .002 
     RV EF (%) 53.6 ± 4.1 54.0 ± 4.0 0.2 (0.0 to 0.7) <.001 
     RV SV (ml/m
2
) 40.1 ± 6.1 40.5 ± 6.1 0.2 (0.0 to 0.6) <.001 
Data are expressed as mean ± SD or median (IQR). EDV = end-diastolic volume, EF = ejection 
fraction, ESV = end-systolic volume, IQR = interquartile range LV = left ventricle, RV = right 
ventricle, SD = standard deviation, SV = stroke volume, ToF = tetralogy of Fallot 
  
 
The increase of RV ejection fraction is mainly the result of decrease in end-systolic 
volume when using the end-systolic frame of the RV instead of the LV. Using the 
end-systolic frame of the RV instead of the LV resulted in a relative increase in 
ejection fraction of 7%, from 45 ± 7% to 48 ± 7%, in patients with ToF and of 1%, 
from 54 ± 4% to 54 ± 4%, in control subjects. The relative increase in ejection 
fraction and stroke volume by using the end-diastolic frame of the RV instead of 
the LV was <1% in both patients with ToF and control subjects. 
In 17 (26%) patients with ToF the absolute increase of ejection fraction exceeded 
5% (range 5-8%), figure 2C. In 39 (60%) patients with ToF ejection fraction fell 
short of the limit of 47% indicating abnormal RV function according to reference 
values [15]. When using the end-systolic frame of the RV instead of the LV frame, 
RV function changed to normal in 5 (13%) of these patients. None of the patients 


































ejection fraction was .98, .91, .87 and .98, .97, .95 in patients with ToF and .94, .93, 







and interobserver ICC for RV end-systolic volume, end
 
Figure 2. 
ventricular volumes and 
function. Scatterplots
change in RV end
volume (A), end
volume (B) and ejection 
fraction (C) when using the 
end
diastolic frame of the RV 
instead of the LV. EDV = 
end
ejection fraction, ESV = end
systolic volume,
ventricular, RBBB = right 
bundle branch block, RV = 
right ventricular, ToF = 
tetralogy of Fallot
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Our study is the first to quantitatively demonstrate the difference in RV volumes 
and function between using the RV and LV end-systolic and end-diastolic frame. 
Performing cardiovascular MRI derived measurements of RV volumes using the LV 
end-systolic and end-diastolic frame, misrepresent RV end-systolic and end-
diastolic volumes in many patients with ToF, especially in the frequent case of a 
complete RBBB. These findings can be of clinical importance in the evaluation of 
the RV in patients with ToF. 
        Previous echocardiographic and cardiovascular MRI studies reported on the 
electromechanical delay of the RV compared to the LV in patients with congenital 
heart disease and normal subjects [8-10,17,18]. The main focus of the 
echocardiographic studies was to assess intra- and interventricular dyssynchrony 
and their predictors. They showed that in patients with ToF RV free wall 
contraction lags behind LV free wall and interventricular septum contraction. 
Although they did not report on timing of end-systole, it can be expected that end-
systole is also delayed. We showed that in most scans of patients with ToF, end-
systole of the RV was more than one frame delayed compared to the LV. This was 
probably largely due to the longer QRS duration in patients with ToF and a 
complete RBBB. In control subjects the normal physiologically electromechanical 
delay of the RV could not be detected in every case as the delay was smaller than 
the time (mean 34 ± 7 ms) between two frames. Therefore, the end-systolic frame 
of the RV was in the same or one frame later than the end-systolic frame of the LV.  
In contrast to end-systole, timing of end-diastole of the RV and LV was similar in 
patients with ToF and control subjects. 
        One small (N=12) cardiovascular MRI study indicated that measuring RV 
volumes in the two frames preceding RV end-systole causes no clinically significant 
volume changes despite the observation that end-systole of RV and LV occur in 
different frames [19]. Our study has made clear that in end-systole the two 
previous frames have a larger volume. When there is a difference in timing of end-
systole of the RV and LV with two or more frames, as is the case in most patients 
with ToF, this leads to a significant change in volume. When there is a difference in 
end-systole of the RV and LV in control subjects, this leads to a very small volume 
change only. QRS duration, unfortunately not documented in the above study [19], 
appears to be an important parameter as evidenced by the statistically significant 
correlation with the difference in end-systolic volume when using the end-systolic 
frame of the RV instead of the LV in patients with ToF obtained in this study. The 



























patients who are rather homogeneous in terms of QRS duration. In contrast to 
end-systole, in end-diastole the adjacent frames had a similar volume.   
        According to the guidelines of the ESC and ACC/AHA, indication for 
replacement of the pulmonary valve in patients with ToF and moderate/severe 
pulmonary regurgitation is based on several parameters including RV function 
[1,2]. It is important in this context that in 13% of the patients with ToF who were 
considered to have abnormal function (ejection fraction <47%) [15], ejection 
fraction increased to normal when using the end-systolic frame of the RV instead 
of the LV. The change in RV function was mainly due to the decrease in RV end-
systolic volume when using the RV frame instead of the LV frame. Studies 
comparing RV volumes and function before and after pulmonary valve 
replacement have identified pre-operative threshold values for RV volumes after 
which volumes can return to normal [3-6]. None of these studies describe whether 
they selected the end-systolic and end-diastolic frame of the RV separately from 
the LV. The reported threshold for RV end-systolic volume above which RV volume 
does not return to normal after PVR varies between approximately 80 and 90 
ml/m
2 
[3-6]. When using a threshold for RV end-systolic volume of > 85 ml/m
2 
[3], 
in our study 25 (39%) patients had volumes above this threshold when measuring 
RV volumes in the end-systolic frame of the LV. When using the end-systolic frame 
of the RV instead of the LV, the end-systolic volume dropped below this threshold 
in 7 (28%) patients. In some of these cases CMR measurements of RV volumes and 
function may prove to be decisive when considering reoperation. Therefore, RV 
volumes should be measured in end-systolic of the RV and not of the LV. 
 
Limitations 
Identifying tricuspid valve opening and closing in a 4-chamber or RV 2-chamber 
view may allow for more accurate selection of the end-systolic frame. However, in 
the 4-chamber view the opening and closing of the tricuspid valve was not always 
clearly visible and RV 2-chamber views were not acquired.  
        There are possible confounders for the difference in timing of end-systole 
between the studied groups, such as the difference in age, pulmonary stenosis and 
regurgitation, RV end-systolic and end-diastolic volume and underlying disease. 
However, it is unlikely that the difference in age will have influenced our results as 
age does not affect timing of contraction of the right and left ventricle [8]. 
Possibly, a stronger correlation would have been found between QRS duration and 
the difference in ejection fraction and end-systolic volume when using the end-
systolic and end-diastolic frame of the RV instead of the LV when also patients 
with ToF and normal QRS duration had been included in this study. To investigate 
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the influence of QRS duration and RBBB more thoroughly, an additional group of 
patients with ToF and no conduction delays would be useful. However, these 
patients are rare and in our institution there are only three CMR scans of these 
patients available over the last three years [1].  
        Although we have shown that end-systolic volume of the RV in patients with 
ToF should be measured in the end-systolic frame of the RV instead of the LV, it is 
uncertain whether this applies to all patients with congenital heart diseases 
involving the right ventricle and a RBBB.  
 
Conclusions 
Independent selection of the end-systolic and end-diastolic LV and RV frame 
instead of using the LV end-systolic and end-diastolic frame for RV determinations, 
results in more accurate end-systolic RV volumes in patients with ToF and a RBBB. 
The differences are significant and correlate with QRS duration. For clinical 
decision making in patients with ToF and a RBBB, RV volumes should be measured 
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Purpose: To validate a novel semi-automatic segmentation algorithm for MR-
derived volume and function measurements by comparing it with the standard 
method of manual contour tracing.  
  
Methods: The new algorithms excludes papillary muscles and trabeculae from the 
blood pool, while the manual approach includes these objects in the blood pool. 
An epicardial contour served as input for both methods. Multiphase 2D steady-
state free precession short axis images were acquired in 12 subjects with normal 
heart function and in a dynamic anthropomorphic heart phantom on a 1.5T MR 
system. In the heart phantom, manually and semi-automatically measured cardiac 
parameters were compared to the true end-diastolic volume (EDV), end-systolic 
volume (ESV) and ejection fraction (EF). In the subjects, the semi-automatic 
method was compared to manual contouring in terms of difference in measured 
EDV, ESV, EF and myocardial volume (MV). For all measures, intra- and inter-
observer agreement was determined.  
 
Results:  In the heart phantom, EDV and ESV were underestimated for both the 
semi-automatic . As the papillary muscles were excluded from the blood pool with 
the semi-automatic method, EDV and ESV were approximately 20 ml lower in the 
patients, whereas EF was approximately 16 % higher. Intra- and inter-observer 
agreement was overall improved with the semi-automatic method compared to 
the manual method. Correlation between manual and semi-automatic 
measurements was high (EDV: R = 0.99, ESV: R = 0.96; EF: R = 0.80, MV: R = 0.99).  
 
Conclusion: The semi-automatic method could exclude endoluminal muscular 
structures from the blood volume with significantly improved intra- and inter-
observer variabilities in cardiac function measurements compared to the 
conventional, manual method, which includes endoluminal structures in the blood 
volume. 
 







Quantification of left ventricular (LV) volumes and mass is important for the 
diagnostic and prognostic assessment in a variety of cardiovascular diseases [1,2]. 
The golden standard for assessment of these quantities is cardiovascular magnetic 
resonance (CMR) imaging, due to its high reproducibility and accuracy [3,4]. The 
current clinical practice is to manually draw epicardial and endocardial contours in 
the end-diastolic and end-systolic phase of the cardiac cycle. The inclusion of the 
papillary muscles in the blood volume introduces a considerable bias in the 
measured volumes and ejection fraction [5]. This bias is generally accepted, as 
manually excluding the papillary muscles by drawing non-convex endocardial 
contours  is even more time consuming and has demonstrated a higher intra- and 
inter-observer variability [6].   
        However, reliable determination of trabecular volumes can be clinically 
relevant in patients with left ventricular hypertrophy [7] or in patients with 
noncompaction cardiomyopathy [8-10]. In these cases, automated segmentation 
of blood and muscle could not only provide faster and more objective analysis, but 
may also yield more accurate estimations of cardiac volumes and function than the 
manual method. Several automated segmentation techniques have been 
proposed, ranging from semi-automatic to fully automated [11-16]. They were, 
however, not designed to separately assess trabecular and papillary muscle 
volumes.  
        The purpose of our study was to validate a novel semi-automatic 
segmentation algorithm by comparing it with the standard method of manual 
contour tracing.  In an anthropomorphic heart phantom, the accuracy of volume 
and function measurement was assessed. In twelve subjects with normal cardiac 
function, the effect of including papillary muscles and trabeculae in the myocardial 





































Materials and methods 
 
Heart phantom 
A dynamic anthropomorphic heart phantom (Shelley Medical Imaging 
Technologies, London, Ontario, Canada) was used to compare the semi-automatic 
and manual method in terms of accuracy.  
        The heart phantom was made of a hydrogel filled with water, placed in a 
water-filled tank. The phantom was connected to a mechanical pump that mimics 
the cyclic filling and emptying of the heart. The ejection fraction (EF) was set at 
61% (end-diastolic volume (EDV): 69 ml, end-systolic volume (ESV): 27 ml). During 
acquisition, the heart rate was 44 beats per minute. The phantom has distinct 
boundaries between the cavities and the wall, and does not include any 
trabeculations nor papillary muscles.  
 
Subjects 
Analysis was performed on normal CMR scans obtained from twelve subjects 
suspected of myocardial infarction. Normal CMR scans were defined as normal 
anatomy, normal contractibility, normal volumes and function with no signs of 
infarction. This retrospective study was approved by the University Medical Center 
Groningen review board and informed consent was not required according to the 
Dutch Medical Research Involving Human Subjects act.  
 
Image acquisition  
Heart phantom 
Imaging was performed on a clinical 1.5 tesla scanner (Sonata, Siemens 
Healthcare, Erlangen, Germany) equipped with a body array coil. A 2D steady-state 
free precession (SSFP) sequence was used to acquire a series of multiphase short 
axis images of the heart. The number of cardiac phases was 25, and 12 slices with 
slice thickness 6 mm and interslice gap of 4 mm were acquired. Total TR was 40 
ms, TE 1.2 ms and the flip angle was 80°. Matrix size was 144 × 192, and pixel size 
1.7 × 1.7 mm.   
 
Subjects 
The subjects were positioned in a supine position in a 1.5T scanner (Avanto, 
Siemens Healthcare, Erlangen, Germany) with a 6-element body matrix coil. The 
protocol included multiple single-slice SSFP series with 25 cardiac phases. The 
single slice images were positioned along the short axis of the left ventricle. To 
cover the entire heart, 15 images with slice thickness 6 mm and interslice gap of 4 
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mm were acquired. Total TR was 45 ms, TE 1.3 ms and the flip angle was 80°. 




Image analysis  
Image analysis was performed manually by using QMass MR (version 7.2, Medis, 
Leiden, The Netherlands) and semi-automatically by using QMass MR research 
edition (Medis, Leiden, The Netherlands).  
        Slice selection: The end-systolic and end-diastolic frames were selected by 
visual assessment. The basal slice was selected with the aid of long-axis cine view 
images. The basal slice of the LV was defined as the most basal slice surrounded 
for at least 50% by the LV myocardium. Slices at the apex were included when 
blood was clearly visible. Contours were drawn manually by tracing the 
endocardial and epicardial borders in every slice in end-systole and end-diastole.  
Contour tracing was aided by reviewing the multiple phase scans in the movie 
mode.  
        Manual method: For the manual method, the EDV and ESV were defined as 
the total volume of voxels within the endocardial contour in the end-diastolic and 
end-systolic phase, respectively. The myocardial volume (MV) was defined as the 
total volume of voxels between the epicardial and epicardial contours in the end-
diastolic phase. The manual method included papillary muscles and trabeculae in 




Figure 1. Segmentation 
according to the manual 
(panels a and c) and semi-
automatic method (panels b 
and d) for the end-diastolic and 
end-systolic phase (ED and ES, 
respectively). For the manual 
method, epi- and endocardial 
contours (green and red lines, 
respectively) are drawn. For 
the semi-automatic method, 
within the epicardial contour 
voxels are classified as either 
muscle (red) or blood (grey).   
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        Semi-automatic method: The epicardial contour served as input for the semi-
automatic method. As the semi-automatic threshold-based segmentation 
algorithm was an integral part of QMass, both methods used the same epicardial 
contour. Within the epicardial contour, voxels were classified as either blood or 
muscle based on their signal intensity. A detailed description of the segmentation 
procedure can be found in Appendix I. The EDV and ESV were defined as the total 
volume of voxels classified as blood within the epicardial contour. The MV was 
defined as the total volume of voxels classified as muscle within the epicardial 
contour in the end-diastolic phase. With the semi-automatic method, the papillary 
muscles and trabeculae were excluded from the blood volume. For both methods, 
the ejection fraction (EF) was defined as: 
 
EF = EDV - ESV
EDV
	 ∙ 100%                                 (1) 
 
        Heart phantom: The deviation from the ground truth of both methods was 
evaluated by comparing the EDV, ESV and EF with the predefined parameters of 
the heart phantom. Contours were drawn by five observers, who were blinded for 
each others results.  
        Subjects: To assess inter-observer agreement, contours were drawn by two 
observers, who both repeated their measurements for intra-observer agreement 
evaluation. Observer 1 had several years of experience and Observer 2 was 
inexperienced. The observers were blinded for the outcomes of the other observer 
and their previous measurements. The observers drew in the same amount of 
slices, such that the comparison would be purely between methods and not on 
how many slices each observer chose to include.  
 
Statistical analysis  
Statistical analysis was performed in SPSS (SPSS 18, Chicago IL, USA) For the heart 
phantom study, a paired Wilcoxon signed rank test was used to assess the 
difference in EDV, ESV and EF between the manual and semi-automatic method. 
To see whether there was a significant difference between the ground truth and 
measured values, a one-sample Wilcoxon signed rank test was applied. 
For the subject study, the difference in measured EDV, ESV, MV and EF between 
the manual and semi-automatic method was tested with a paired Wilcoxon signed 
rank test, using the average of the four observations for each subject. The 
correlation between both methods was assessed with the Pearson’s correlation 
coefficient. 
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        The intra-observer agreement coefficient (ACintra) between paired 
observations was calculated for each observer: 
 
  ACintra = 100 ∙ 1 − 2 ∙ |Obs1 − Obs2|
Obs1 + Obs2  																		(2) 
 
For each observer, the median ACintra was computed. Similarly, the inter-observer 
agreement coefficient ACinter was computed. For each observer, the average of the 
two paired observations was used.  The difference in median AC between the 
manual and semi-automatic method was tested with a paired Wilcoxon signed 








































Compared to the ground truth (ESVgt = 27 ml), the ESV was underestimated with 
both the manual (median: 21.7; range: 18.4 – 22.6 ml; p = 0.04) and semi-
automatic method (median: 22.7 ml; range: 21.1 – 25.1 ml; p = 0.04). For the EDV 
(EDVgt: 69 ml), a significant underestimation between measured volume and 
ground truth was found for the manual method (median: 65.1 ml; range: 61.6 – 
66.0 ml; p = 0.04), but not for the semi-automatic method (median: 67.8 ml; range: 
66.0 – 69.4 ml; p = 0.09).  
        Underestimation of the EDV and ESV resulted in an overestimation of EF 
(ground truth: 61 %) for both the manual (median: 67.2 %; range: 65.3 – 70.1 %; p 




The correlation between the semi-automatic and manual method was high for all 





Figure 2 Correlation between the semi-automatic and manual method for (panel a) the end-
diastolic and end-systolic  volumes (ESV (open squares) and EDV (black diamonds), respectively) 
and myocardial volume (MV, crosses), as well as (panel b) the ejection fraction. 
 
 
With the semi-automatic method, the EDV and ESV were lower compared to the 
manual method (p < 0.01). The median difference between semi-automatic and 
manual method, which reflected the volume of trabeculae and papillary muscles, 
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was 20 ml (range: 9 – 29 ml) for the EDV and 23 ml (range: 14 – 34 ml) for the ESV. 
The difference in end-diastolic MV between the semi-automatic and manual 
method was equal to the difference in EDV. With the semi-automatic method, the 
estimated ejection fraction was approximately 16% higher (p < 0.01) compared to 
the manual method (range: 8 – 24 %). 
        Overall, observer agreement was higher for the semi-automatic method 
compared to the manual method (Figure 3). For the inexperienced observer 2, the 
semi-automatic method gave a significantly higher intra-obsever agreement 
coefficient for both the EDV (p = 0.03) and ESV (p < 0.05). In contrast, for the 
experienced observer no difference in ACintra was found for the EDV (p = 0.53) or 
ESV (p = 0.08). ACinter of the semi-automatic method was significantly improved for 
the semi-automatic method compared to the manual method for the ESV (p = 
0.04), but not for the EDV (p = 0.24).  
        For the ejection fraction, the semi-automatic method yielded a higher ACinter 
(p = 0.03) and ACintra (p < 0.01 for observer 1 and p = 0.01 for observer 2) 
compared to the manual method.  The intra-observer agreement for the 
myocardial volume determined with the semi-automatic method was significantly 
improved for the inexperienced observer (p = 0.01), but not for the experienced 
observer (p = 0.17). ACinter for MV was higher for the semi-automatic method 







































Figure 3. Intra- and inter-observer coefficients of agreement for the manual (grey) and semi-
automatic method (white) for the end-diastolic (EDV, panel a ), end-systolic (ESV, panel b), 
ejection fraction (EF, panel c) and myocardial volumes (panel d) . Observer 2 is the inexperienced 





In this study, a semi-automatic segmentation algorithm has been presented which 
segments blood and muscle within a user-provided epicardial contour. The 
algorithm was tested on CMR data of a dynamic heart phantom with known 
volumes, and in subjects with normal heart function.   
        An important feature of the semi-automatic segmentation procedure was that 
the papillary muscles and trabeculae were included in the myocardial volume 
rather than in the blood volume. In the subject study, this led to notably lower 
EDVs and ESVs with the semi-automatic method compared to the manual method. 
It also has a pronounced effect on the ejection fractions, which were considerably 
higher for the semi-automatic method. In this study, all ejection fractions found 
with either method were within the normal range, and the recorded difference 
would not be relevant for clinical decision-making. However, other studies have 
demonstrated that including the papillary muscles and trabeculae in the 
myocardial volume can have consequences for patient management [17], 
especially in patients with myocardial hypertrophy [7]. Further research is needed 
to indicate which measure is clinically most relevant.    
        Variations in drawing the contours was the main source of intra- and inter-
observer variations in both the semi-automatic and manual method. However, for 
the semi-automatic method only the epicardial contour was required. Compared 
to the endocardial contour, the epicardial contour is generally less user-
dependent, because the contrast between myocardium and surrounding tissues is 
usually higher. Moreover, delineation of the endocardial contour was in most 
subjects complicated by the presence of papillary muscles and trabeculae. This 
was especially true for the ESV, where the endoluminal muscular structures lied 
against the myocardial border. As a result, observer agreement was significantly 
improved for the semi-automatic method compared to the manual method.  
        For the phantom, both the manual and semi-automatic method 
underestimated the volumes. The discrepancy between true and measured 
volumes may be caused by the exclusion of the most basal slice from the total 
volume. Due to partial volume effects, no pure blood was present in this slice. 
Inclusion would have led to overestimation of the blood volumes. Moreover, 
because the delineation of the endocardial contour was less pronounced, it might 
have increased the inter-observer variation for both the manual and semi-
automatic method.  
        In the phantom study, the semi-automatic method gave slightly larger blood 




































% is too high for this situation. Whether this is only true for the heart phantom, 
which in this experiment had a higher blood-myocardium contrast than a real 
heart remains to be investigated. 
 
Conclusion 
With the semi-automatic method, endoluminal muscular structures could be 
excluded from the blood volume with significantly improved intra- and inter-
observer agreement in cardiac function measurements compared to the 
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The semi-automatic segmentation method (QMass MR research edition, Medis, 
Leiden, The Netherlands) was based on the signal intensity distribution of MR 
images. The technique of normalized convolution [18] is used to estimate the 
spatially varying blood and muscle intensities within a user-provided epicardial 
contour. The voxel intensity is defined by a first order model with six variables: 
 




Muscle: Im (x,y) = a0 + a1x + a2y    (2) 
Blood: Ib (x, y) = b0 + b1x + b2y 
   
where a0, a1, a2, b0, b1 and b2 are constants that vary among scans according to the 
grey value distribution of the image within the epicardial contour. Im(x,y) and 
Ib(x,y) represent the approximation of the intensity of muscle and blood, 
respectively, at the position (x,y) (see Figure A).  The constants are obtained with 
an iterative optimization procedure, during which the weight w(x,y) is initialized to 
either 1 or 0 using the Otsu threshold method [19]. The procedure is stopped 
when the classification w > 0.5 is unaltered between iterations or when the 
number of iterations exceeds ten. 
 
Assuming a linear relationship between the fraction of blood and the intensity of 
the voxel (I(x,y)), the weight w(x,y) represents the fraction of blood in the voxel. 
 
w (x,y) = I(x,y) - Im	(x,y)
Ib	(x,y) - Im	(x,y) 																																																												(3) 
 
A binary classification is obtained by thresholding w(x,y). If w(x,y) is higher than 
the threshold value, the voxel is considered pure blood, otherwise it is defined as 
pure muscle. In this experiment the threshold value was set to 70%. Blood volume 
measures are obtained by multiplying the number of voxels classified as blood 





































Note that this method does not distinct trabeculations from papillary muscle and 
as such stands out from methods that do specifically target the papillary muscles 




Figure A Segmentation procedure. Panel a shows a short axis view of the heart. The signal 
intensities along the red line in panel a are represented in panel b. The algorithm fits two planes 
(represented by the solid black lines) through the highest (blood) and lowest (muscle) signal 
intensities within the epicardium. A threshold plane was defined at 70 % between the two 
intensity planes. Voxels with signal intensities above this threshold are considered pure blood, 
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Purpose: To assess the impact of right ventricular (RV) trabeculae and papillary 
muscles on measured volumes and function assessed by cardiovascular magnetic 
resonance imaging in patients with repaired tetralogy of Fallot.  
 
Methods: Sixty-five patients with repaired tetralogy of Fallot underwent routine 
cardiovascular magnetic resonance imaging. Endocardial and epicardial contours 
were drawn manually and included trabeculae and papillary muscles in the blood 
volume. Semi-automatic threshold-based segmentation software excluded these 
structures. Both methods were compared in terms of end-diastolic, end-systolic 
and stroke volume, ejection fraction and mass. Observer agreement was 
determined for all measures. 
 
Results: Exclusion of trabeculae and papillary muscle in the RV blood volume 
decreased measured RV end-diastolic volume by 15% (from 140 ± 35 ml/m
2
 to 120 
± 32 ml/m
2
) compared to inclusion, end-systolic volume by 21% (from 74 ± 23 
ml/m
2
 to 59 ± 20 ml/m
2
), stroke volume by 9% (from 66 ± 16 ml/m
2
 to 60 ± 16 
ml/m
2
) and relatively increased ejection fraction by 7% (from 48 ± 7% to 51 ± 8%) 
and end-diastolic mass by 79% (from 28 ± 7 g/m
2
 to 51 ± 10 g/m
2
), p<.01. 
Excluding trabeculae and papillary muscle resulted in an improved interobserver 
agreement compared to including these structures (coefficient of agreement of 
87% vs 78%, p < .01) 
 
Conclusions: Trabeculae and papillary muscle significantly affect measured RV 
volumes, function and mass. Semi-automatic threshold-based segmentation 
software can reliably exclude trabeculae and papillary muscles from the RV blood 
volume. 
 






Tetralogy of Fallot (ToF) is the most common congenital heart disease involving 
the right ventricle (RV). Important complications during follow-up after repair for 
ToF are RV volume overload. Longstanding volume overload can result in 
irreversible RV dilation and dysfunction which can be prevented by timely 
replacing the pulmonary valve [1-5]. Furthermore, many patients have some 
amount of pressure overload caused by residual outflow tract obstruction, 
stenosis of a pulmonary artery branch or stenosis of a valve prosthesis. Therefore, 
evaluation of the RV is essential in the follow-up of patients with ToF [6,7]. 
        Guidelines advise cardiac magnetic resonance imaging (CMR) as the primary 
imaging modality for evaluation of RV volumes and function [6,7]. Consensus is 
lacking on whether to consider trabeculae and papillary muscles as part of 
measured RV volumes [8-10]. Including trabeculae and papillary muscles in RV 
volumes results in larger measured volumes compared to measurements with 
exclusion of these structures. In healthy subjects and patients without congenital 
heart disease, the influence of trabeculae and papillary muscle on RV volumes is 
too small to be of clinical importance [9]. The increase in papillary muscle and 
trabeculae can be large in patients with a systemic right ventricle [10]. However, 
no studies have addressed the influence of papillary muscle and trabeculae on 
measured RV volumes in patients with repaired ToF. Studies in patients with ToF 
including trabeculae and papillary muscles in the RV blood volume report larger RV 
volumes and lower RV mass than studies excluding these structures [11-14]. 
Therefore, knowledge of the quantity of trabeculae and papillary muscles and the 
possibility to estimate this amount could be of clinical importance in patients with 
ToF. 
        The primary objective of our study was to determine the trabecular volume of 
the RV and the reliability by which it can be measured in patients with repaired 
ToF. The second objective was to create a mathematical model that describes the 
relation between the RV volumes with and without inclusion of trabeculae and 







































Materials and methods 
 
Patients 
The study population consisted of 65 patients with repaired ToF. All patients 
underwent CMR examination between January 2008 and January 2011. In 60 
(92%) patients primary indication for CMR was follow-up of RV volumes and 
pulmonary flow parameters, in 3 (5%) patients sudden decrease in exercise 
capacity, in 1 (2%) patient new onset of ventricular tachycardia and in 1 (2%) 
patient poor echocardiographic image quality. In 24 (37%) patients clinical 
symptoms were present: subjective reduced exercise capacity in 14 (22%) patients, 
history of supraventricular tachycardia in 5 (8%) patients and history of ventricular 
tachycardia in 5 (8%) patients. Other patient characteristics are shown in table 1.  
         This retrospective study was approved by the University Medical Center 
Groningen review board and informed consent was not required according to the 
Dutch Medical Research Involving Human Subjects act. 
 
 
Table 1 Patient characteristics  
Characteristic  
Male 37 (57) 
Age (years) 30 ± 10 
Body surface area (m
2
) 1,86 ± 0,19 
Age at total repair (years) 1.76 ( 0.89 – 5,05) 
Pulmonary valve replacement 15 (23) 
Pulmonary regurgitation fraction (%) 34 (15 – 45)  
Pulmonary regurgitation volume (ml/m
2
) 18 (7 – 30)  
Pulmonary valve peak flow velocity (cm/s)  187 ± 75 
Data are mean ± standard deviation, median (IQR), or number of subjects (%) 
 
 
CMR image acquisition 
All subjects were examined on a 1.5-Tesla MRI system (Siemens Magnetom 
Sonata, Erlangen, Germany or Siemens Magnetom Avanto, Erlangen, Germany) 
using a 2 x 6 channel body-coil. After single-shot localizer images, short axis cine 
loop images with breath holding in expiration were acquired using a 
retrospectively gated balanced steady state free precession sequence. Parallel 
imaging was employed using GRAPPA (GeneRalized Autocalibrating Partially 
Parallel Acquisition). To improve image intensity uniformity Prescan Normalize was 
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used. Short axis slices were planned in end-diastole from two slices above the 
mitral valve plane to the apex. The following parameters were used: TR 2.7 ms, TE 
1.1 ms, flip angle 80
o
, matrix 192 x 192 mm, 25 frames per cycle, slice thickness 6 
mm, interslice gap 4 mm, voxel size 1.7 x 1.7 x 6 mm. 
        Two-dimensional velocity encoded MRI flow measurements perpendicular 
and directly cranial to the pulmonary valve was performed to quantify flow 
velocity and volumes. Encoded velocity was 200 cm/s which was increased in steps 
of 50 cm/s in case of aliasing. 
 
CMR image analysis 
Image analysis was performed manually by using QMass MR (version 7.2, Medis, 
Leiden, The Netherlands) and semi-automatically by using QMass MR research 
edition (Medis, Leiden, The Netherlands). 
        The end-systolic and end-diastolic frames of the RV were selected by visual 
assessment. The basal slice was selected with aid of long-axis cine view images. 
When the pulmonary valve was visible in the RV basal slice, only the portion of the 
right ventricular outflow tract below the level of the pulmonary valve was 
included. The inflow part of the RV was included in the RV volume. The RV inflow 
part was distinguished from the right atrium by recognizing the trabeculated and 
thick right ventricular wall compared to the thin right atrial wall [15]. RV contours 
were drawn manually by tracing the endocardial and epicardial borders in every 
slice in end-systole and end-diastole. Contour tracing was aided by reviewing the 
multiple phase scans in the movie mode.  
        Two methods were used to measure RV volumes, function and mass (see 
figure 1). Method 1 excluded papillary muscle and trabeculae from the RV blood 
volume by using semi-automatic threshold-based segmentation software. Method 
2 included these structures in the endocardial contour and therefore the blood 
volume. The semi-automatic threshold-based segmentation software was based 
on the signal intensity distribution of MR images. The voxels within the epicardial 
contour were classified as either blood or muscle according to their signal 
intensity, taking into account spatial variations in signal intensity. Based on their 
signal intensity, trabeculae and pappilary muscles were included in the myocardial 
volume. Users had the possibility to manually change the threshold level of signal 
intensities above which voxels are depicted as blood for every slice. Selecting and 
deselecting individual voxels was possible, for example in case of artefacts due to 
mechanical pulmonary valve prosthesis. As the semi-automatic threshold-based 







































same endocardial and epicardial contours. A more detailed description of the 




Figure 1. Two methods were used to measure RV volumes. In Method 1, trabeculae and papillary 
muscle were excluded from the right ventricular volume with use of semi-automatic threshold-
based segmentation software (a). In Method 2, trabeculae and papillary muscle were included in 
the right ventricular volume (b).  
 
 
        Stroke volume was defined as end-diastolic volume minus end-systolic 
volume. Ejection fraction was defined as stroke volume divided by end-diastolic 
volume. Mass is derived from myocardial volume after multiplying by the density 
of cardiac muscle, 1.05 g/cm
3
. All volumes were indexed for Body Mass Index. 
        To obtain agreement between observers, 25 randomly selected CMR scans 
were analysed by a second independent observer. For agreement within one 
observer, the same 25 scans were analysed a second time by the first observer 
with an interval of at least two weeks between the first and second analysis.  
 
Statistical analyses 
The Statistical Package for the Social Sciences version 16.0 (SPSS Inc, Chicago, IL) 
was used for all statistical analyses. All statistical tests are two-sided and a P-value 
of less than .05 was considered statistically significant. 
        Descriptive statistics were calculated as mean and standard deviation for 
normally distributed continuous variables, median with interquartile range (IQR) 
for non-normally distributed continuous variables and absolute numbers and 
percentages for dichotomous variables. The manual and semi-automatic methods 
were compared in terms of RV volume, mass and function by using the paired-
samples Student’s t-test.  
 63 
        The intraobserver agreement coefficient (ACintra) between paired observations 
was calculated for both observers: 
 
  ACintra = 100 ∙ 1 − 2 ∙ |Obs1 − Obs2|
Obs1 + Obs2  																		(1) 
       
For the first observer, the median ACintra was computed. The interobserver 
agreement coefficient ACinter was also determined. For both observers, the average 
of the two paired observations was used. The difference in median AC between 
the manual and semi-automatic method was assessed with a paired Wilcoxon 
signed rank test. 
        Linear regression was used to examine the relationship between RV volume 









































RV volumes and function 
Exclusion (Method 1) instead of inclusion (Method 2) of trabeculae and papillary 
muscle in the RV blood volume resulted in a significant change in measured RV 
volumes and function. When Method 1 was compared to Method 2, end-diastolic 
volumes were 15 ± 4% (from 140 ± 35 ml/m
2
 to 120 ± 32 ml/m
2
), end-systolic 
volumes 21 ± 5% (from 74 ± 23 ml/m
2
 to 59 ± 20 ml/m
2
) and stroke volumes 9 ± 
5% (from 66 ± 16 ml/m
2
 to 60 ± 16 ml/m
2
) smaller (p < .01). Ejection fractions were 
7 ± 4% (from 48 ± 7% to 51 ± 8%) and the end-diastolic masses were 79 ± 21% 
(from 28 ± 7 g/m
2
 to 51 ± 10 g/m
2
) larger (p < .01). The difference in RV end-
diastolic volumes, RV end-systolic volumes, RV ejection fraction and RV end-
diastolic mass between Method 1 and Method 2 increased as volumes, ejection 
fraction and mass became larger (see figure 2). Exclusion of trabeculae and 
papillary muscle took an average of 67 ± 16 seconds extra time compared to 
inclusion of these structures.  
 
Observer agreement 
The intra- and interobserver reproducibility data are shown in table 2. Observer 
agreement was high in all measurements with exception of RV mass. Method 1 
resulted in a significantly higher ACintra and ACinter for RV mass (p < .01). The ACintra 
for RV end-diastolic volume was significantly higher for Method 2 (p = .02). 
 
Model 
The amount of trabeculae increased with increasing end-diastolic and end-systolic 
volumes. Based on this relationship the following model was created: 
 
RVexcl = a ∙ RVincl + b    (2) 
 
RVexcl and RVincl were RV volumes in which the trabeculae and papillary muscles 
were excluded and included, respectively. For end-diastolic volumes the constant 
a and b from equation 2 were .90 (95% CI .87 to .94) and -7.04 ml/m
2
 (95% CI -2.29 
to -11.79 ml/m
2
), respectively. For end-systolic volumes, a was .87 (95% CI .84 to 
.90) and b  -5.30 ml/m
2









Figure 2. Bland-Altman plots visualizing the differences between Method 1 and Method 2 for 
measurements of (a) right ventricular end-diastolic volume, (b) right ventricular end-systolic 
volume, (c) right ventricular stroke volume, (d) right ventricular ejection fraction and (e) right 
ventricular end-diastolic mass. The X-axis depicts the mean value of Method 1 and Method 2 for 
each parameter. The Y-axis depicts the difference in measurements between Method 1 and 
Method 2. The continuous line represents the mean difference between Method 1 and Method 2 
for each measurement and the dotted line represents the mean difference ± 1.96 standard 
deviations between Method 1 and Method 2. RVED mass = right ventricular end-diastolic mass, 
RVEDV = right ventricular end-diastolic volume, RVEF = right ventricular ejection fraction, RVESV 
= right ventricular end-systolic volume, RVSV = right ventricular stroke volume. 
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Table 2 Interobserver and intraobserver coefficients of agreement of right ventricular volume 
and function measurements for Method 1 and Method 2 
 RVEDV  RVESV  RVSV  RVEF  RV mass  
Interobserver      
Method 1      
  Mean diff. ± SD 0.4 ± 7.7 -0.5 ± 6.5 0.6 ± 3.8 0.4 ± 3.9 -2.2 ± 8.8 
  95% CI -14.7 to 15.5 -13.3 to 12.2 -6.9 to 8.1 -7.2 to 8.0 -19.4 to 15.0 
  AC (%) 96  95  93  95 87 
Method 2      
  Mean diff. ± SD 1.1 ± 10.7 2.4 ± 7.3 -0.6 ± 4.5 -1.5 ± 3.8 -2.8 ± 7.0 
  95% CI -19.9 to 22.2 -11.9 to 16.6 -9.5 to 8.3 -9.0 to 6.0 -16.5 to 11.0 
  AC (%) 95 94 91 95 78 
  P Value .43 .86 .21 .56 <.01 
Intraobserver      
Method 1      
  Mean diff. ± SD 5.1 ± 6.8 4.2 ± 5.4 0.4 ± 3.4 -1.2 ± 3.6 1.9 ± 4.4 
  95% CI -8.3 to 18.5 -6.4 to 14.9 -6.3 to 7.2 -8.3 to 5.8 -6.8 to 10.6 
  AC (%) 95 95 95 97 93 
Method 2      
  Mean diff. ± SD 2.7 ± 7.1 3.9 ± 7.2 -0.7 ± 3.3 -1.8 ± 3.6 4.6 ± 3.3 
  95% CI -11.2 to 16.6 -10.0 to 18.0 -7.1 to 5.7 -8.8 to 5.2 -1.9 to 11.1 
  AC (%) 97 96 93 96 85 
  P Value .02 .19 .72 .40 <.01 
Volumetric data are expressed in ml/m
2
, and mass in g/m
2
. 95% CI = 95% confidence interval, 
AC = agreement coefficient, diff = difference, Method 1 = exclusion of papillary muscle and 
trabeculae from the RV blood volume, Method 2 = inclusion of papillary muscle and 
trabeculae in the RV blood volume, RV mass = right ventricular end-diastolic mass, RVEDV = 
right ventricular end-diastolic volume, RVEF = right ventricular ejection fraction, RVESV = right 







Our study is the first to show the impact of trabeculae and papillary muscle on RV 
volume measurements in a large group of patients with repaired tetralogy of 
Fallot. Semi-automatic threshold-based segmentation software provided a 
reproducible method to differentiate myocardium from blood. Compared to 
including papillary muscle and trabeculae from the RV blood volume, exclusion of 
the papillary muscle and trabeculae in the RV blood volume resulted in 
significantly decreased end-systolic and end-diastolic volumes and increased 
ejection fraction and mass. Manually delineating RV trabeculae and papillary 
muscles has a low reproducibility in patients with increased trabeculae and is time-
consuming [10]. Therefore, many studies in patients with ToF have included these 
structures in the blood volume. Our study showed that with semi-automatic 
threshold-based segmentation software it is possible to differentiate myocardium 
from blood with a high reproducibility, which is in line with a previous report [11]. 
This creates the possibility to measure RV blood volume without inclusion of 
trabeculae and papillary muscles. Inclusion or exclusion of trabeculae and papillary 
muscles can have a profound effect on the measured volumes and mass. Our study 
showed a decrease of 21% in end-systolic volume and 15% in end-diastolic volume 
when these structures were excluded from the RV blood pool. The change in 
measured RV mass was very large with an increase of 79%.  
        Most patients with repaired ToF are considered to mainly have a volume-
overloaded. We expected the trabeculae to blood volume ratio to be much less in 
our patients with ToF than reported in patients with systemic RVs. However, 
compared to patients with systemic RVs in a study by Winter et al., the change in 
volume was similar in patients with repaired ToF for end-diastolic volume (15% for 
both groups) and smaller for the end-systolic volume (21% vs 27%) when 
trabeculae and papillary muscle were excluded from the RV blood pool [10]. It is 
difficult to compare our results with those from the study by Winter et al. as they 
delineated trabeculae and papillary muscles manually to differentiate blood from 
muscle, instead of semi-automatic with threshold-based segmentation software. 
In our study, no direct comparison was made between these two methods 
because of the aforementioned disadvantages of manually delineating trabeculae 
and papillary muscles [10]. 
        Although the amount of trabeculae and papillary muscles should be the same 
in end-systole and end-diastole, stroke volume was 6 ml/m
2
 larger when including 
compared to excluding these structures. A possible explanation is that the amount 







































RV wall is difficult in end-systole due to compression of the trabeculae against the 
RV wall. Therefore, contour tracing was aided by reviewing the multiple phase 
scans in the movie mode. Based on movement and position of the trabeculae 
during the entire heart cycle, it was possible to interpolate the position of the 
endocardial contour. Some of the trabeculae were possibly considered to be RV 
wall in end-systole and not in end-diastole. Another explanation is that the 
amount of trabeculae was overestimated in end-diastole. Trabeculae can be better 
distinguished from the RV wall in end-diastole. However, this will result in more 
voxels containing both blood and trabeculae and too much of these voxels were 
possibly considered to be trabuculae and not blood. 
        The existing RV reference values are based on RV volumes including 
trabeculae and papillary muscles. When papillary muscles and trabeculae are 
excluded from the blood volume, use of these reference values is no longer valid. 
Until new reference values are developed in which the trabeculae and papillary 
muscles are excluded, it is possible to use the proposed model in patients with ToF 
to allow comparison with the old reference values. The same applies to the 
application of threshold values. An important threshold is the use of RV end-
diastolic volume for timing pulmonary valve replacement in patients with ToF [1-
5]. The reported thresholds range from 82 to 90 ml/m
2
 for end-systolic volume and 
150 to 170 ml/m
2
 for end-diastolic volumes. Some of these differences may be 
explained by including or excluding trabeculae and papillary muscles in the 
measured volumes. Unfortunately, only one of these studies reported whether 
they included RV trabeculae and papillary muscles in the measured volumes [2].  
 
Limitations and future perspectives 
A gold standard for the amount of endocardial trabeculae of the RV is lacking. 
Therefore, a validation in vivo was not possible. However, exclusion of trabeculae 
and papillary muscle should be theoretically more accurate as these structures are 
part of the myocardium and not blood. 
        In our study, measurements of RV volumes and function were highly 
reproducibility. However, an axial orientation could have resulted in an even 
higher reproducibility and also a higher accuracy in patients with a severely dilated 
RV [16,17]. 
        Our study was limited to patients with repaired ToF as this is the most 
common severe congenital heart disease in adult patients. To determine the 
influence of trabeculae in the RV volume in other patient groups, more research is 
required. Our study showed that semi-automatic threshold-based segmentation 
software is a valuable tool for further research in this area.  
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Conclusion 
RV endocardial trabeculae significantly influence measured RV volumes and mass. 
Exclusion compared to inclusion of trabeculae and papillary muscle in the RV blood 
volume results in a significantly decrease in measured end-systolic and end-
diastolic volume and increase in measured ejection fraction and mass. Semi-
automatic threshold-based segmentation software can exclude trabeculae and 
papillary muscles from the RV blood volume in a reproducible manner. Currently 
used ranges and thresholds for congenital heart disease patients should be re-
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Objectives: Cardiac magnetic resonance imaging (CMR) is the preferred method to 
measure right ventricular (RV) volumes and ejection fraction (RVEF). This study 
aimed to determine the impact of trabeculae and papillary muscles on RV volumes 
and function in patients with pressure overloaded RVs and its reproducibility using 
semi-automatic software. 
 
Material and methods: Eighty patients with pressure overloaded RVs (pulmonary 
hypertension, transposition of the great arteries after arterial switch operation 
and after atrial switch procedure and repaired tetralogy of Fallot) and 20 healthy 
controls underwent short-axis multislice cine CMR. End-diastolic volume (EDV), 
end-systolic volume, RV mass and RVEF were measured using 2 methods and 
compared using paired samples T-test.  First, manual contour tracing of RV endo- 
and epicardial borders was performed. Thereafter, trabeculae were excluded from 
the RV blood volume using semi-automatic pixel-intensity based software. Twenty-
five datasets were re-analyzed, to assess intra- and interobserver agreement. 
 
Results: Exclusion of trabeculae resulted in significantly decreased EDV; ranging 
from a decrease of -5.7 ± 1.7 ml/m
2 
in healthy controls to -29.2 ± 6.6 ml/m
2
 in 
patients after atrial switch procedure. RVEF significantly increased in all groups, 
ranging from an absolute increase of 3.4 ± 0.8% in healthy controls up to 10.1 ± 
2.3% in patients after atrial switch procedure. Observer agreement was high for all 
measurements. 
 
Conclusions: In patients with pressure overloaded RVs exclusion of trabeculae 
from the blood volume results in a significant change in RV volumes, RVEF and RV 
mass and is highly reproducible when semi-automatic pixel-intensity based 
software is used. 
 




Both in patients with pulmonary hypertension (PH) and in patients with different 
types of congenital heart disease (CHD), the right ventricle (RV) performs under 
increased pressure loading. The RV adapts by hypertrophying, however at a certain 
point the RV is unable to cope with the increased pressures and RV failure will 
ensue. Consequently, RV function is an important determinant of prognosis and of 
therapeutic strategy in these patients. For instance, in patients with pulmonary 
valvular (PV) stenosis, timing of intervention is partly dependent on RV function 
[1].  In patients with PH, deterioration of RV ejection fraction (RVEF), increased RV 
end-diastolic volume (RVEDV) and stroke index are associated with poor outcome 
[2,3]. Furthermore, for patients with systemic RV after atrial switch operation, 
decline in RV function is one of the most important clinical problems. Therefore RV 
volumes and function are used frequently in follow-up of these patients, making 
accurate and reproducible measurements highly important.  
        As 2D and also 3D echocardiography of the RV remain less accurate and 
reproducible than cardiac magnetic resonance imaging (CMR), the latter is still 
considered to be the reference standard for the quantification of RV volumes and 
EF [4-7]. Whether trabeculae and papillary muscles should be included or excluded 
from the blood volume is subject of debate. Throughout literature both methods 
are used [2,8-10]. However, in many studies it is not clearly described whether 
trabeculae and papillary muscles were included or excluded from the RV blood 
volume [11-14]. The impact of trabeculae is assumed to be small in healthy 
individuals, but Winter et al. showed that exclusion of trabeculae from the RV 
blood volume resulted in a substantial difference of RVEDV, RV end-systolic 
volume (RVESV) and RVEF in patients with a systemic right ventricle[15]. Although 
theoretically more accurate, Winter et al. also showed that manual tracing of 
trabeculae has low reproducibility and therefore can be considered less favorable 
for longitudinal follow-up [5,15]. 
        Freling et al. recently reported that semi-automatic pixel-intensity based 
segmentation software is able to exclude trabeculae and papillary muscles from 
the RV blood volume with high reproducibility in tetralogy of Fallot (ToF) patients 
with volume overloaded RVs. Moreover, this resulted in a substantial difference in 
RV volumes and RVEF compared to the standard method which includes these 
structures in the RV blood volume [16]. However, impact and reproducibility of 
excluding trabeculae and papillary muscles with this semi-automatic software in 









































        The purpose of the current study was to determine the impact of trabeculae 
and papillary muscles on RV volumes and function as assessed by CMR in different 
patient groups with pressure overloaded RVs and to determine the reproducibility 




Study design and population 
One hundred patients were included in the analysis (median age 36.2 years, 51% 
male). Four groups of 20 adult patients with pressure overloaded RV’s were 
analyzed: patients with pre-capillary PH, patients with right ventricular outflow 
tract obstruction (RVOTO) after arterial switch operation (ASO) for transposition of 
the great arteries (TGA), patients with repaired ToF and patients with TGA and 
atrial switch procedure (Mustard or Senning operation). A reference group of 20 
healthy controls was also included. 
        Pre-capillary PH was defined as a mean pulmonary artery pressure of  ≥ 25 
mmHg and a pulmonary capillary wedge pressure of ≤ 15 mmHg in accordance 
with ESC/ESR guidelines [17]. All patients with PH had an established diagnosis of 
either chronic thrombo-embolic PH or idiopathic PH. In all patients RV systolic 
pressure (RVSP) was measured using Doppler echocardiography on the day of CMR 
investigation. RVSP was measured using the peak velocity of tricuspid insufficiency 
plus estimated right atrial pressure. Patients with repaired ToF were included if a 
RVSP of ≥ 36 mmHg was measured by Doppler echocardiography [18]. Patients 
after ASO were included if RVSP measured by Doppler echocardiography was ≥ 36 
mmHg or if, using Doppler echocardiography, a mild or moderate RVOTO was 
measured, defined as a maximum gradient of ≥ 25 mmHg. For patients with TGA 
and atrial switch procedure systolic blood pressure was used to determine RVSP. 
Basic patient characteristics for each patient group are illustrated in table 1.  
        In this retrospective study, MR images from two tertiary referral hospitals 
were analyzed. One centre contributed 59 patient CMR datasets and 20 control 
subjects. The second centre provided the remaining 21 patient CMR datasets. The 
datasets in this study were obtained between May 2008 and July 2012. Prior to 
analysis, all patient and control data were encoded to preserve anonymity. All 
CMR datasets were acquired in a routine clinical setting and anonymized for 
analysis. The medical ethics committees waived the need for informed consent. 
 
CMR imaging protocol 
Datasets were obtained using commercially available 1.5 T MR imagers (Ingenia 
R4.1.2; Philips Healthcare, Best, The Netherlands [n = 79]; Magnetom Sonata, 
Siemens Healthcare; [n = 7] and Magnetom Avanto; Siemens Healthcare, Erlangen, 
Germany [n = 14]). For all studies dedicated chest or torso phased array parallel-
imaging capable surface coils were used with 12-28 elements. CMR images were 









































using a retrospectively gated balanced steady state free precession sequence with 
25-30 cardiac phases per cardiac cycle. Slice thickness varied between 6-8 mm 
with an interslice gap of 0 - 4 mm. Sequences included multi-slice, multi-phase cine 
short-axis, longitudinal four-chamber, vertical two-chamber and RV outflow views. 
The multi-slice cine short-axis acquisitions were planned from above the mitral 
valve up to and including the cardiac apex. The following ranges of other scan 





171 - 192; voxel size: 1.25 x 1.25 x 8.0 mm and 1.7 x 1.7 x 6.0 mm. Parallel imaging 
factors varied between 0 - 3. 
 
 




n = 20 
ASO 
n = 20 
ToF 
n = 20 
Atrial Switch 
n = 20 
Controls 
n = 20 
Male gender (n (%)) 7 (35) 11 (55) 11 (55) 12 (60) 10 (50) 
Age (year) * 55.0 ± 14.1 24.9 ± 4.0 29.1 ± 7.8 33.0 ± 6.3 36.7 ± 10.1 
BSA (m
2





n = 20 
40 (37-53) 
n = 15 
45 (41-50) 
n = 20 
120(106-125) 




 - 35 (29-42) 
n = 8 
33 (30-40) 
n = 15 
- 4 (3-8) 
n = 20 
# Data presented as median (IQR) ,* Data presented as mean ± SD. ASO = arterial switch 
operation, BSA = body surface area, PH = pulmonary hypertension, RVESP = right ventricular 
esnd-systolic pressure, RVOT = right ventricular outflow tract, ToF = tetralogy of Fallot. 
 
 
CMR image analysis 
Image analysis was performed using Qmass MR Research edition version 7.4.14.0 
(Medis, Leiden, the Netherlands) [16]. Segmentation was performed on end-
diastolic and end-systolic phases only. End-diastolic and end-systolic phases were 
selected by visual assessment as the phase with the largest and smallest RV cavity 
sizes, taking into account the longitudinal four-chamber, vertical two-chamber and 
RV outflow tract as reference views. If visual assessment was difficult, multiple 
frames were contoured to determine the correct end-diastolic or end-systolic 
phase. Using a previously described RV analysis protocol the RV epicardial and 
endocardial contours were manually traced from the most apical to the most basal 
short-axis slice [19]. Only the portion of the outflow tract below the pulmonary 
valve was included in the blood volume in the basal slice in which the pulmonary 
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valve was visible. If more than 50% of the tricuspid annulus or atrium was visible in 
a basal slice the valve area was excluded from the blood volume. Epi- and 
endocardial contours overlapped at valve borders and septum as the septum was 
considered part of the left ventricle. For patients with systemic RV, the septum 






Figure 1. RV contours and semi-automatic selection of trabeculae.Two methods of measuring RV 
volumes in a healthy control (A) and patient after atrial switch procedure (B). Method 1: inclusion 
trabeculae in the blood volume (A-1 and B-1); Method 2: exclusion of trabeculae from the blood 
volume, using identical endocardial contours (A-2 and B-2).  
  
Based on the methodology described above, two methods were used for 









































papillary muscles were included in the blood volume. With method 2, trabeculae 
and papillary muscles were excluded from the blood volume (Figure 1). Selection 
of trabeculae and papillary muscles was done using a semi-automatic threshold-
based segmentation software. The segmentation software is based on the signal 
intensity distribution of MR images and has been described in detail by Freling et 
al [16]. In brief, voxels within the epicardial contour are classified as either blood 
or muscle according to their signal intensity, taking into account spatial variations 
in signal intensity. Based on this algorithm, trabeculae and papilary muscles were 
excluded from the blood volume and included in the myocardial volume. It is a 
possibility to manually change the thresholds for every slice, in order to select the 
same trabeculae in end- diastole and end-systole. Observers selected only 
trabeculae with signal intensity similar to the intensity of right ventricular 
myocardium. Selection and deselection of individual voxels was also possible in 
case of artifacts due to nonlaminar flow.  
        For both methods RV volumetric parameters were calculated by the sums of 
the traced contours multiplied by slice thickness in all short-axis slices. For method 
1 the volume of trabeculae and papillary muscles were included in the RV blood 
volume and for method 2 they were excluded from the blood volume. Stroke 
volume (SV) was defined by the difference between end diastolic volume (EDV) 
and end systolic volume (ESV). All volumetric data were indexed for body surface 





).  EF was calculated by SV/ EDV * 100%. For 
method 1 myocardial volume was defined as epicardial minus the endocardial 
contour, for method 2 end-diastolic trabecular volume was added to the 
myocardial volume. RV mass was quantified by multiplying the specific density of 
myocardium (1.05 g/ml) with the end-diastolic myocardial volume.  
 
Reproducibility 
Intraobserver reproducibility of both methods was assessed by re-analyzing 5 
randomly selected CMR datasets from every patient group, as well as the healthy 
control subjects by the primary observer. In total 25 datasets were reanalyzed. To 
determine interobserver variability a second observer re-analyzed the same 25 
datasets. Observers were blinded for earlier results and there was an interval of at 
least two weeks between the first and second analysis. The observers had equal 





Continuous data were expressed as median and interquartile range (IQR) or mean 
value ± standard deviation (SD) as appropriate. Mean differences ± SD between 




, RVEF and RV 
mass/m
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RVEF found in the patient groups were compared to the healthy control group 
using a one-way ANOVA with posthoc Dunnett’s test. For the one-way ANOVA 
data underwent logarithmic transformation if necessary (i.e. if homogeneity of 
variances was inequal).  P-values of <0.05 were considered statistically significant. 
        Intra- and interobserver agreement were assessed using Bland-Altman plots 
and intraclass correlation coefficients (ICC). Paired Student’s T-test was used to 
test for significant differences between observer 1 and 2 and between the first and 
second measurements of observer 1. Mean differences ± SD for all measurements 
were calculated. All data analysis was performed in IBM SPSS statistics version 20.0 
















































, RV EF and RV mass measured including (method 1) and 
excluding (method 2) RV trabeculae from the RV blood volume (method 2) are 
listed in table 2. For all patient groups and for healthy controls, exclusion of 





 and a significantly increased RVEF (table 2).  
 
 
Table 2. RV volume, mass and ejection fraction measured with inclusion (method 1) and 
exclusion of trabeculae from the RV blood volume (method 2). 










117.4 ± 31.8 
105.1 ± 28.4 
-12.3 ± 4.6* 
99.4 ± 23.3 
88.3 ± 21.2 
-11.1 ± 3.3* 
147.0 ± 42.5 
124.8 ± 38.0 
-22.2 ± 6.0* 
139.9 ± 33.6 
110.7 ± 28.7 
-29.2 ± 6.6* 
96.9 ± 18.9 
91.2 ± 17.8 








75.4 ± 30.0 
62.7 ± 25.9 
-12.7 ± 4.8* 
50.1 ± 13.3 
39.2 ± 11.3 
-10.9 ± 3.3* 
85.5 ± 27.8 
63.7 ± 23.2 
-21.8 ± 6.0* 
85.9 ± 26.2 
57.1 ± 21.7 
-28.8 ± 6.5* 
47.5 ± 11.5 
41.6 ± 10.5 








42.0 ± 7.9 
42.4 ± 8.0 
-0.4 ± 0.6** 
49.3 ± 11.7 
49.2 ± 11.5 
-0.2 ± 0.6 
61.5 ± 19.4 
61.0 ± 19.6 
-0.4 ± 0.8** 
54.0 ± 14.9 
53.6 ± 14.7 
-0.4 ± 0.9 
49.4 ± 8.6 
49.6 ± 8.6 








18.5 ± 5.5 
31.4 ± 9.8 
12.9 ± 4.9* 
20.1 ± 5.0 
31.1 ± 7.5 
11.0 ± 4.8* 
25.4 ± 7.1 
48.7 ± 12.3 
23.3 ± 6.3* 
43.3 ± 9.1 
73.9 ± 15.4 
30.6 ± 6.9* 
13.0 ± 3.0 
19.0 ± 4.2 






37.2 ± 8.5 
41.9 ± 9.1 
4.7 ± 1.6* 
49.6 ± 5.0 
55.8 ± 5.1 
6.1 ± 1.7* 
42.1 ± 6.9 
49.4 ± 12.3 
7.2 ± 1.7* 
39.2 ± 7.8 
49.3 ± 9.7 
10.1 ± 2.3* 
51.3 ± 3.8 
54.7 ± 4.1 
3.4 ± 0.8* 
Data are presented as mean ± SD. *p < 0,001 using paired Student’s T-test; ** p < 0.05 using 
paired Student’s T-test. ASO = arterial switch operation, M = Method, PH = pulmonary 
hypertension, RVEDV = right ventricular end-diastolic volume, RVEF = right ventricular 
ejection fraction, RVESV = right ventricular end-systolic volume, RVM = right ventricular mass, 
RVSV = right ventricular stroke volume, ToF = tetralogy of Fallot. 
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Also a significant difference in RVSV/m
2
 was found. However, for all populations 
the mean difference in RVSV was very small, <0.5 mL/m
2
. The differences between 
both methods were most pronounced in the patients after atrial switch procedure 
and least pronounced in the PH patients, with mean absolute differences in EF of 
10.1 ± 2.3% and 4.7±1.6%, respectively. In healthy controls an absolute increase in 
RVEF of 3.4 ± 0.8% was measured. By excluding trabeculae volume from the blood 
volume, and including them with RV mass, this parameter also significantly 





and RV mass were significantly larger in all patients groups compared to the 
healthy controls (p<0.01).  
 
Reproducibility 
For both methods inter- and intraboserver agreement was high in all 
measurements, as illustrated by high ICCs with small limits of agreement (table 3 & 
figure 2). For both methods, RVEDV, RVESV and RV mass showed significant 
differences between repeated measurements. However, mean differences were 
small and considered not clinically relevant. In figure 2, Bland-Altman plots show 
interobserver variability for RVESV, RVEDV and RVEF for both methods. For RVEDV, 
RVESV and RV mass the limits of agreement were narrower when trabeculae and 
papillary muscles were excluded from the RV blood volume (method 2).  
 
 
Table 3. Inter- and intraobserver agreement 
  Interobserver (obs 2 – obs 1
I
) Intraobserver (obs 1
II
 – obs 1
I
) 
ICC Mean  
diff ± SD 
P-
value 
ICC Mean  









-2.4 ± 6.7 





2.8 ± 5.1 









-2.3 ± 5.2 





1.1 ± 4.2 
1.0 ± 3.8 
0.209 
0.194 




0.9 ± 2.6 





0.4 ± 1.8 









5.8 ± 3.5 





0.5 ± 2.3 
0.3 ± 3.2 
0.283 
0.694 
P-value obtained using paired student T-test. M = Method, Obs 2 = second observer, Obs 1
I
 = 
first measurement of primary observer, Obs 1
II
 = second measurement of primary observer, 
RVEDV = right ventricular end-diastolic volume, RVEF = right ventricular ejection fraction, 










































Figure 2. Bland-Altman plots for method 1 and method 2 Bland-Altman plots showing the mean 
value of both observers on the x-axis and absolute differences between the observers on the y-
axis for each paired observation. Limits of agreement are defined as ± 2 SD. Obs = observer, 
RVEDV = right ventricular end-diastolic volume, RVEF = right ventricular ejection fraction, RVESV 















































































































































Exclusion of trabeculae and papillary muscles resulted in substantial alterations of 
RV volumes, RVEF and RV mass in a wide range of patient populations with 
pressure overloaded RVs. Furthermore, we found that these differences in RV 
parameters vary widely depending on the exact condition underlying RV overload. 
Although prior studies already established this fact in general terms, the major 
impediment to widespread adoption of this method in clinical practice was the 
lack of a fast and reproducible way to measure the exact amount of RV trabeculae 
and papillary muscles.  We found that exclusion of RV trabeculae using semi-
automatic pixel-intensity based software resulted in fast and highly reproducible 
RV measurements. This is opposed to manual tracing of trabeculae which has 
previously been shown to be unreliable [15,20]. 
        Accurate and reproducible measurement of RV volume and function is 
mandatory because of the prognostic and therapeutic consequences in patients 
with PAH and CHD [1,3,21,22]. The impact of excluding trabeculae from the RV 
blood volume was previously illustrated in patients with systemic RVs and ToF with 
volume overloaded RVs [15,23]. The current study underscores that exclusion of 
trabeculae has a substantial impact on RV volumes, RVEF and RV mass in CHD and 
PAH patients with RV pressure overload. Healthy controls also exhibited significant 
differences in all RV measurements, but these were significantly smaller compared 
to the differences observed in patient groups. Consequently, RV volume and 
function in most patients will be closer to the normal range after trabeculae are 
excluded from the RV blood volume. 
        To date the major obstacles to exclude trabeculae and papillary muscles from 
the RV blood volume have been the time investment of performing manual tracing 
of these structures and the low reproducibility [15,20]. In the current study we 
found that using semi-automatic threshold-based segmentation software results in 
improved accuracy of RV volumetric measurements with high reproducibility. 
Because in- or exclusion of trabeculae from the RV blood volume has a major 
impact on RV parameters as measured with CMR, studies using different 
methodologies are incomparable. Several major studies in CHD patients differ on 
the point of in- or excluding RV trabeculae and papillary muscles from the RV 
blood volume [3,4,11,12,20,22,24] or are not clear about which methodology was 
used [13,14]. Application of the method described in this study may be a step 
forward to achieve uniformity of RV volumetric measurements, which is important 










































        When comparing the current study to prior studies investigating the impact of 
trabeculae and papillary muscles on RV volume and function, some important 
differences can be observed. Winter et al. studied 29 patients with systemic right 
ventricles and found an increase in RVEF of 7.4± 3.9 % compared to 10.1 ± 2.3 % in 
our report. In contrast to our results, which are based on semi-automated pixel-
intensity based segmentation, manual exclusion of trabeculae was substantially 
less reproducible in the study of Winter et al [15].  Moreover, both our study as 
well as the study by Freling et al. reported a higher reproducibility for RVEDV, 
RVESV and RV mass using this semi-automatic method to exclude trabeculea 
compared to only endocardial contour tracing [23]. We attribute this finding to 
observer variation in handling of trabeculae adjacent to the endocardial border, 
which can result in small differences for endocardial contour tracing, which will be 
rectified if all trabeculae are excluded. Sievers et al. studied the effect of 
trabeculae on RV volumes in healthy controls and reported a difference in RVEF of 
only 1.72% compared to 3.4 ± 0.8% in our study, however baseline RVEDV values 
also differed considerably with ours, indicating that these study populations  are 
not comparable [25]. Freling et al. investigated ToF patients with volume 
overloaded RV’s using the same software package as described in the current 
study and found a similar increase in RVEF of 7 ± 4 %, versus 7 ± 2% in our study 
[23].  
        The current study only focused on one of the possible sources of error in RV 
volumetric assessement with CMR.  An important source of error remains basal 
slice selection and delineation of the tricuspid valve. A short-axis orientation for 
RV volumetric measurement was used in this study as this is standard practice in 
our hospitals. Axial orientation, however, might result in higher reproducibility 
than short-axis orientation in CHD patients with severely dilated RVs, decreasing 
the difficulty of valve delineation in the basal slices [26,27].  To minimize errors at 
the tricuspid and pulmonic valve, images were cross linked to RV 2-chamber, 4-
chamber and RV outflow tract views. Furthermore only a small portion of the 
patients had severely dilated RVs, therefore it is unlikely that the slice orientation 
would have resulted in important differences for the current study. The impact 
and reproducibility of the semi-automatic software used in the current study will 
likely be similar in axial slice orientation, as the software is not restricted by 
geometric assumptions and uses signal intensity to select trabeculae. Finally, 
another source of error might be inadequate selection of the RV end-systolic 
frame. In daily practice both RV and LV ESV are often assessed in the LV end-
systolic frame. However in patients with CHD, who often have right bundle branch 
block, timing of the RV end-systolic frame can be delayed compared to the LV end-
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systolic frame [28]. We choose RV end-diastolic and end-systolic phase based 
solely on RV cavity size. 
        This study is unable to determine whether in- or excluding trabeculae best 
represents true RV volumes, as a gold standard in vivo is lacking. However, 
theoretically exclusion of trabeculae is more accurate as they do not contribute to 
RVEDV and RVESV.  
 
Conclusion 
Exclusion of trabeculae and papillary muscles has a substantial impact on 
measured RV volumes, mass and EF. The magnitude of the differences varied 
between patient groups and was significantly larger in all patient groups when 
compared to healthy controls. Semi-automatic pixel-intensity based software 
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Background: Patients with tetralogy of Fallot (ToF) and combined right ventricular 
(RV) outflow tract obstruction (RVOTO) and pulmonary regurgitation (PR) have 
compared to patients without RVOTO more favorable RV volumes and function. 
Unknown is whether RVOTO is also associated with improved exercise capacity. 
 
Methods: Cardiac magnetic resonance imaging, echocardiography and exercise 
tests were compared between 12 patients with and 30 patients without RVOTO 
(Doppler peak RVOT gradient (RVOT-PG) ≥ 30 mmHg). 
 
Results: Patients with RVOTO had smaller RV end-systolic (50 ± 16 versus 64 ± 18 
ml/m
2
) and end-diastolic volumes (117 ± 24 versus 135 ± 28 ml/m
2
) and higher RV 
mass (52 ± 14 versus 42 ± 11 ml/m
2
) than patients without RVOTO, p < .050.  RV 
ejection fraction did not differ significantly between patients with and without 
RVOTO (58% ± 8% versus 53% ± 7%), p = 0.051. Degree of PR, left ventricular 
volumes and function were not different between both groups. Patients with 
RVOTO had a significant lower peak oxygen uptake (25 ± 3 versus 32 ± 8 
ml/kg/min) and percentage of predicted peak oxygen uptake (63% ± 7% versus 
79% ± 14%) than patients without RVOTO, p < 0.001. In multivariate analysis 
RVOT-PG was the only independent predictor of exercise capacity. 
 
Conclusions: Exercise capacity is lower in patients with compared to patients 
without RVOTO despite more favourable RV volumes at rest and comparable 
degree of pulmonary regurgitation. Therefore, exercise capacity should be 
considered in addition to RV volumes and function in patients with ToF and PR. 
 




Most adult patients with repaired tetralogy of Fallot (ToF) have longstanding 
pulmonary regurgitation (PR). PR results in chronic right ventricular (RV) volume 
overload, and has been related to RV dilation, RV dysfunction, symptomatic heart 
failure, ventricular arrhythmia and sudden death [1-3].  
        In addition to PR, many patients have residual RV outflow tract obstruction 
(RVOTO) resulting in some amount of pressure overload. Animal studies 
demonstrated that RVOTO may limit the negative impact of PR on RV size and 
myocardial contractility. Increase in cardiac output during dobutamine infusion 
was not different between animals with PR and animals with combined RVOTO 
and PR [4,5]. This suggests that despite smaller RV volumes with higher myocardial 
contractility, patients with combined RVOTO and PR may not have better exercise 
capacity than patients with isolated PR. Indeed, despite smaller RV size in patients 
with ToF and combined RVOTO and PR as demonstrated in recent studies, New 
York Heart Association functional class did not differ compared to patients with 
isolated PR [6,7] However, since functional class is known to be poorly correlated 
with objective exercise capacity [8,9], it remains unclear what the effect of RVOTO 
is on exercise capacity. 
        Therefore, we performed a study to evaluate the effects of RVOTO on exercise 
capacity, RV volumes and RV function in adult patients with repaired ToF and 









































This retrospective study was approved by the University Medical Center Groningen 
review board. Informed consent was not required according to the Dutch Medical 
Research Involving Human Subjects act.         
        Our institute’s cardiac magnetic resonance (CMR) imaging database contained 
123 patients with repaired ToF without a pulmonary valve replacement. We 
included patients in whom adequate echocardiographic examination, exercise 
testing and CMR imaging were performed within 6 months of each other (n = 48; 
39%) and no clinical relevant event occurred in the meantime. All examinations are 
part of routine follow up in our center. Patients with significant regurgitation or 
stenosis of other valves than the pulmonary valve and residual intracardiac shunts 
were excluded (n = 5). The remaining 42 patients were divided into two groups: 12 
patients with combined PR and RVOTO and 30 patients with PR and no RVOTO. 
RVOTO was defined as a Doppler peak pressure gradient across the RVOT of > 30 
mm Hg. 
 
Cardiac magnetic resonance imaging 
All subjects were examined on a 1.5-Tesla MRI system (Siemens Magnetom 
Sonata, Erlangen, Germany or Siemens Magnetom Avanto, Erlangen, Germany) 
using a 2 x 6 channel body-coil. After single-shot localizer images, short axis cine 
loop images with breath holding in expiration were acquired using a 
retrospectively gated balanced steady state free precession sequence. The 
following parameters were used: TR 2.7 ms, TE 1.1 ms, flip angle 80
o
, matrix 192 x 
192 mm, 25 frames per cycle, slice thickness 6 mm, interslice gap 4 mm, voxel size 
1.7 x 1.7 x 6 mm.  
        Two-dimensional velocity encoded MRI flow measurements perpendicular 
and directly cranial to the pulmonary valve was performed to quantify flow 
velocity and volumes. 
 
Cardiac magnetic resonance image analysis 
Analysis of CMR images has been described previously [10-12]. In summary, image 
analysis was performed semi-automatically by using QMass MR research edition 
(Medis, Leiden, The Netherlands). LV and RV contours were drawn manually by 
tracing the endo- and epicardial borders in every slice in the end-systolic and end-
diastolic frame. The end-systolic phase of the RV was selected independently from 
the LV. Papillary muscles and trabeculae were excluded from the RV blood volume 
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and included in the mass. Stroke volume was calculated by subtracting the end-
systolic volume from the end-diastolic volume. Ejection fraction was obtained by 
dividing stroke volume by end-diastolic volume.  
        Analysis of MRI flow measurements was performed using QFlow version 5.2 
(Medis, Leiden, The Netherlands. Contours were drawn manually in all 30 phases. 
PR was quantified as PR fraction and PR volume. All ventricular volumes were 
indexed for body surface area. 
 
Echocardiography 
Continuous-wave Doppler was used to determine the maximum velocity across 
the RV outflow tract. The RV outflow tract gradient was calculated with use of the 
simplified Bernoulli equation. The presence of restrictive physiology was defined 
as forward flow across the pulmonary valve during end-diastole. The tricuspid and 
left-sided valves were reviewed for significant stenosis or regurgitation. All 
patients were screened for the presence of residual intracardiac shunts. 
 
Exercise testing 
A treadmill cardiopulmonary exercise test was performed in all patients. Workload 
was incremented at regular intervals with a combination of speed and grade. 
Because the expected maximum workload was relatively low in most patients, a 
modified Bruce protocol was used in which workload starts at a relatively low level 
and increases more gradually than in the standard Bruce protocol [13]. At the first 
stage speed was 1.7 miles/hour and incline 0%, at the second stage the same 
speed and 5% incline, and the third stage corresponded to the first stage of the 
Bruce protocol. Cardiopulmonary exercise testing ended when patients reached 
their peak oxygen uptake (VO2), could not keep up with the treadmill speed, 
breathing reserve dropped and O2 heart rate decreased, or discontinuation was 
indicated for safety reasons. Peak VO2 was calculated as the average VO2 for the 
two highest measurements at peak exercise and expressed as millilitre per minute 
per kilogram and as percentage of predicted maximum VO2. Respiratory exchange 
ratio was computed as carbon dioxide production/VO2. Exercise tests were only 
included if the patient reached the anaerobic threshold, defined as having a 
respiratory exchange ratio > 1.0. 
 
Analysis 
Descriptive statistics were calculated for all measurements as mean and standard 










































for dichotomous variables. Differences in characteristics between patient groups 
were analyzed using Student’s T-test for normally distributed continuous variables 
and Mann-Whitney U-test for skewed continuous variables. Fisher’s Exact Test was 
used for comparison of categorized variables. Univariate linear regression analysis 
was performed to determine which variables were significantly related to 
percentage of predicted peak VO2. Variables included were patient characteristics 
(age at exercise testing, gender), operative characteristics (age at repair, usage of 
transannular patch), imaging parameters (CMR measurements of RV volume and 
function and left ventricular function, degree of PR, presence of restrictive 
physiology and peak pressure gradient across the RVOT) and QRS duration. In 
multivariate analysis we evaluated independent predictors of peak VO2. Only 
variables statistically significant (p <.050) in univariate analysis were included in 
the multivariate analysis (backward stepwise regression method). The Statistical 
Package for the Social Sciences version 20.0 (SPSS Inc, Chicago, IL) was used for all 
statistical analyses. All statistical tests are two-sided and a P-value of less than .050 





Patient characteristics were not different between both groups except peak 
gradient across the RVOT (Table 1). Twenty-five (60%) patients were male. Mean 
age at the study was 32 ± 9 years. Previous palliative shunt was performed in 9 
(21%) patients. ToF repair was performed between March 1972 and July 1993 and 




 percentile, 1.3 – 5.7) years. During repair 
22 (54%) patients received a transannular patch. All patients were in NYHA class I 
at time of evaluation for this study, except one patient with isolated PR who was in 
NYHA class II. Mean QRS duration was 136 ± 26 ms and all patients had a right 
bundle branch block. Restrictive physiology was present in 14 (37%) patients and 
could not be determined due to inadequate Doppler signals in 4 (10%) patients. 
Peak pressure gradient across the RVOT on Doppler echocardiography was 24 ± 14 
mmHg, and was 42 ± 9 mmHg in patients with combined RVOTO and PR and 16 ± 6 
mmHg in patients with isolated PR, p <.001.  
 
 
Table 1. Patients’ characteristics 
 Isolated PR  
(N=30) 
Combined RVOTO + PR 
(N=12) 
P 
Male 15 (50) 10 (83) .081 
Age at repair (years) 2.5 (1.3 – 5.5) 3.9 (1.8 – 5.9) .449 
Age at study (years) 30 ± 9 34 ± 9 .246 
Previous palliative shunt 6 (20) 3 (25) .699 
Transannular patch 14 (47) 8 (73)* .173 
NYHA class 
   class I 








Peak gradient RVOT (mmHg) 16 ± 6 42 ± 9 <.001 
Restrictive physiology 10 (37)** 4 (36)** 1.000 
QRS duration (ms) 137 ± 26 132 ± 30 .579 
* Details of the operative procedure could not be retrieved of one patient. ** Presence of 
restrictive physiology could not be determined in four patients, one patient with and three 
patients without RVOTO. Data are presented as number of patients (%), mean ± standard 
deviation or median (25th-75th percentile). NYHA = New York Heart Association, PR = 
pulmonary regurgitation, RVOT = right ventricular outflow tract, RVOTO = right ventricular 







































Patients with combined RVOTO and PR had statistically significant smaller RV end-
systolic and end-diastolic volumes and higher RV mass than patients with isolated 
PR, p <.050. The higher RV ejection fraction in patients with combined RVOTO and 
PR compared to patients with isolated PR was not statistically significant, p = .051. 
Number of patients with PR regurgitation fraction > 20%, severity of PR, LV end-
systolic, end-diastolic and stroke volume, and LV ejection fraction were not 
different between both groups (Table 2). 
 
 
Table 2. Results of cardiac magnetic resonance imaging 
 All ToF 
(N = 42) 
Isolated PR 
(N =30) 
Combined RVOTO + PR 
(N = 12) 
P 
PR percentage (%) 36 ± 15 34 ± 15 38 ± 16 .456 
PR >20% 36 (86) 25 (83) 11 (92) .655 
PR volume (ml/m
2
) 26 ± 15 26 ± 14 27 ± 17 .820 
RVESV (ml/m
2
) 60 ± 18 64 ± 18 50 ± 16 .021 
RVEDV (ml/m
2
) 130 ± 28 135 ± 28 117 ± 24 .049 
RVSV (ml/m
2
) 70 ± 15 71 ± 15 67 ± 14 .448 
RVEF (%) 54 ± 7 53 ± 7 58 ± 8 .051 
RVM (ml/m
2
) 45 ± 13 42 ± 11 52 ± 14 .019 
LVESV (ml/m
2
) 38 ± 9 39 ± 8 37 ± 10 .552 
LVEDV (ml/m
2
) 87 ± 13 88 ± 12 84 ± 13 .398 
LVSV (ml/m
2
) 48 ± 7 49 ± 8 47 ± 6 .483 
LVEF (%) 56 ± 6 56 ± 6 57 ± 6 .674 
LVM (ml/m
2
) 53 ± 8 52 ± 8 55 ± 8 .174 
Data are presented as number of patients (%) or mean ± standard deviation. LEDV = left 
ventricular end-diastolic volume, LVEF = left ventricular ejection fraction, LVESV = left 
ventricular end-systolic volume, LVM = left ventricular mass, LVSV = left ventricular stroke 
volume, PR = pulmonary regurgitation, RVEDV = right ventricular end-diastolic volume, RVEF 
= right ventricular ejection fraction, RVESV = right ventricular end-systolic volume, RVM = 
right ventricular mass, RVSV = right ventricular stroke volume, RVOTO = right ventricular 




Mean time between CMR and exercise testing was 1.9 ± 7.6 weeks. Patients with 
combined RVOTO and PR had a significant lower percentage of predicted peak VO2 
than patients with isolated PR, p < .001. Exercise capacity was impaired, defined as 
peak VO2 < 85% of the predicted value, in all patients with combined RVOTO and 
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PR, and in 20 (67%) patients with isolated PR, p = .040. Heart rate at rest was not 
significantly different between both groups. The lower maximum heart rate and 
lower percentage of predicted maximum heart rate in patients with combined 
RVOTO and PR compared to patients with isolated PR was not statistically 
significant, (Table 3). 
 
 
Table 3. Results of cardiopulmonary exercise testing 
 All ToF 
(N=42) 
Isolated PR  
(N=30) 
Combined 
RVOTO + PR 
(N=12) 
P 
Rest heart rate (bpm) 77 ± 11 77 ± 11 76 ± 11 .800 
MHR (bpm) 170 ± 21 174 ± 17 162 ± 26 .144 
MHR (% of predicted normal values) 90 ± 9 92 ± 7 87 ± 12 .186 
Peak VO2 (ml/kg/min) 30 ± 8 32 ± 8 25 ± 3 <.001 
% of predicted peak VO2 74 ± 15 79 ± 14 63 ± 7 <.001 
Respiratory exchange ratio 1.11 ± 0.07 1.11 ± 0.07 1.12 ± 0.08 .491 
Data are presented as mean ± standard deviation. MHR = maximum heart rate, RVOTO = 
right ventricular outflow tract obstruction, ToF = tetralogy of Fallot, VO2 = oxygen uptake 
 
 
        Univariate analysis showed a statistically significant relation between 
percentage of predicted peak VO2 and peak pressure gradient across the RVOT 
(Figure 1) and RV end-diastolic volume. In multivariate analysis peak pressure 




Table 4. Univariate and multivariate predictors of percentage of predicted peak oxygen uptake 
 Univariate RC ± SE P Multivariate RC ± SE P 
Peak gradient (mmHg) -0.49 ± 0.15 .002 -0.49 ± 0.15 .002 
Constant   86.93 ± 4.10 - 
RVEDV (ml/m
2
) 0.17 ± 0.08 .034  NS 
Data are regression coefficients ± standard errors. R2 for the multiple regression model of 
percentage of predicted peak VO2 was .212. RC = regression coefficient, RVEDV = right 







































 Figure 1. Correlation of percentage of predicted peak oxygen uptake 
and gradient across the right ventricular outflow tract. RVOT = right 




Our study is the first to demonstrate in patients with repaired ToF that combined 
RVOTO and PR is associated with reduced exercise capacity despite more 
favourable RV volumes at rest. Furthermore, peak pressure gradient across the 
RVOT was the only independent predictor  of  percentage  of  predicted  peak  VO2.  
        Experimental studies in growing swine have demonstrated that combined 
RVOTO and PR resulted in more RV hypertrophy, and less dilatation of the RV 
compared to isolated PR [4,5]. Our and other studies in patients with repaired ToF 
confirmed that patients with combined RVOTO and PR had smaller RV volumes 
compared to patients with isolated PR, despite comparable degree of PR [6,7,14]. 
Some studies proposed that decreased diastolic compliance resulting from RVOTO-
induced hypertrophy prevents severe RV dilatation due to limiting PR [7,14]. 
However, we and others found no difference in PR between patients with and 
without RVOTO [6,7]. The RV hypertrophy and decreased compliance might have 
protective properties against RV dilatation, however, the exact mechanism of 
protection against RV dilatation remains unknown. Although smaller RV volumes 
and higher ejection fraction have been considered markers for better RV 
performance in patients with repaired ToF, our results suggest that adaptations of 
the RV in response to RVOTO do not result in increase cardiac output during 
exercise.  
        During exercise, cardiac output increases to deliver the required oxygen and 
nutrients to the muscles. Increase in cardiac output is mainly a result of changes in 
preload, afterload, contractility and heart rate [15]. A healthy untrained person 
can increase cardiac output a little over fourfold, and a well-trained athlete can 
increase output about sixfold [15]. However, increase in cardiac output during 
exercise is decreased in patients with repaired ToF [16]. As the left ventricle and 
RV are in series, cardiac output of the left ventricle is most likely limited because of 
reduced RV output. Under normal circumstances the RV is an energetic efficient 
pump because of the low pressure in the pulmonary circulation [17,18]. In patients 
with repaired ToF and PR energetic inefficiency exists due to enlarged stroke 
volume which for a large part flows back into the RV. Additionally, often intra- and 
interventricular dyssynchrony cause suboptimal coordination of RV contraction 
[19]. RV dilatation results in a changed geometry of both ventricles with reduced 
diastolic LV volume due to septal displacement and paradoxical systolic septal 
movement, which further reduces cardiac output [17,18].  
        Furthermore, when a patient has additional RVOTO, more kinetic energy is 





































contractile force allowing the RV to generate higher pressures. The simplified 
Bernouilli equation states that pressure gradient = 4 x [flow / area]
2
. As a result, 
the increase in pressure during exercise can be quite high given that gradients are 
a square function of flow. The increased contractile force in patients with 
combined RVOTO and PR might not be sufficient to adequately increase cardiac 
output during strenuous exercise. 
        Additionally, RV hypertrophy and degenerative myocardial changes after 
longstanding pressure overload could be detrimental for RV compliance and 
diastolic function. Previous studies have discussed that restrictive physiology, 
visible as forward flow during diastole, is associated with smaller RV volumes and 
improved exercise performance. Like a previous report, we found no difference in 
frequency of restrictive physiology between patients with combined RVOTO and 
PR compared to patients with isolated PR [7]. Furthermore, in our study presence 
of restrictive physiology was not correlated with measured exercise capacity. 
However, this does not rule out that patients with combined RVOTO and PR have 
more often or more severe diastolic dysfunction during exercise. Last, in our data 
there was a trend towards a lower heart rate response during exercise in patients 
with combined RVOTO and PR which further reduces the ability to increase output. 
Therefore, poorer RV function during exercise in patients with combined RVOTO 
and PR is most likely caused by insufficient systolic function, reduced diastolic 
function, reduced heart rate or a combination of those. 
        When pulmonary valve replacement is performed timely in patients with ToF 
and PR, RV volumes will normalize and irreversible RV dysfunction is prevented 
[20,21]. Therefore, timing of pulmonary valve replacement is increasingly being 
based on CMR derived RV volume measurements [22]. As patients with additional 
RVOTO have smaller RV volumes, pulmonary valve replacement will be performed 
less frequently in these patients [23]. Whether optimal timing of pulmonary valve 
replacement to prevent irreversible RV dysfunction in patients with combined 
RVOTO and PR should be guided by RV volumes in the same way as in patients 
with isolated PR is unknown. Since volumes remain smaller in patients with 
additional RVOTO, while our results suggest that exercise capacity is more 
impaired than in patients with isolated PR, it can be postulated that patients with 
combined RVOTO and PR should require different criteria to guide the timing of 
pulmonary valve replacement. Possibly exercise capacity should be given more 
weight while RV volumes may be less important. However, whether more timely 





In our study total repair was performed in different decennia. The trend is to 
perform total repair at an increasingly younger age. This shortens the period the 
patient is subjected to systemic hypoxia and RV pressure overload. Furthermore, 
current surgical strategies to relieve pulmonary stenosis during repair of ToF aim 
at limiting the amount of future PR and mild residual stenosis is accepted. Because 
of the retrospective nature of our study in combination with the long time 
between repair of ToF and our study, we have insufficient data concerning the 
time of onset of RVOTO. It is unknown whether RVOTO has been present since 
repair of ToF or evolved later. We have no CMR or echocardiographic data during 
exercise at our disposal, therefore we can only speculate about the cause of the 
difference in exercise capacity between patients with and without additional 
RVOTO.  
        The number of patients in our study with combined RVOTO and PR is 
relatively small and the degree of RVOTO was only moderate. A larger, preferable 
prospective, study should be performed to confirm whether our results can be 




Currently, timing of pulmonary valve replacement in patient with ToF and PR is 
mainly guided by RV volumes and to a lesser degree exercise capacity. However, 
patients with combined RVOTO and PR have reduced exercise capacity despite 
more favourable RV volumes at rest compared to patients without RVOTO. 
Therefore, exercise testing as well as CMR imaging should be interpreted in 
conjunction with the presence of RVOTO. Whether current guidelines on timing of 
pulmonary valve replacement need to be revised for patients with combined 
RVOTO and PR, giving exercise capacity a more prominent role, should be the 
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Background Data on long-term complications in adult patients with congenital 
heart disease (ACHD) and a prosthetic valve are scarce. Moreover, the influence of 
prosthetic valves on quality of life (QoL) and functional outcome in ACHD patients 
with prosthetic valves has not been studied. 
 
Objectives The primary objective of the PROSTAVA study is to investigate the 
relation between prosthetic valve characteristics (type, size and location) and 
functional outcome as well as QoL in ACHD patients. The secondary objectives are 
to investigate the prevalence and predictors of prosthesis-related complications 
including prosthesis-patient mismatch. 
 
Methods The PROSTAVA study, a multicentre cross-sectional observational study, 
will include approximately 550 ACHD patients with prosthetic valves. Primary 
outcome measures are maximum oxygen uptake during cardiopulmonary exercise 
testing and quality of life. Secondary outcomes are the prevalence and incidence 
of valve-related complications including prosthesis-patient mismatch. Other 
evaluations are medical history, physical examination, echocardiography, MRI, 
rhythm monitoring and laboratory evaluation (including NT-proBNP). 
 
Implications Identification of the relation between prosthetic valve characteristics 
in ACHD patients on one hand and functional outcome, QoL, the prevalence and 
predictors of prosthesis-related complications on the other hand may influence 
the choice of valve prosthesis, the indication for more extensive surgery and the 
indication for re-operation. 
 
* Addendum added to “Prosthetic valves in adult patients with congenital heart 
disease: Rationale and design of the Dutch PROSTAVA study” 
 










Due to the improved survival of children with congenital heart disease (CHD), the 
number of adults with CHD has increased and adult patients with CHD now 
outnumber children [1].  Prosthetic valves, mechanical or biological, are part of the 
treatment in many patients with CHD. Mechanical prosthetic valves may 
negatively influence quality of life because of the necessity for anticoagulation 
therapy, which can hamper the active lifestyle of young adult patients with CHD 
and which prevents women from going through untroubled and safe pregnancies 
[2]. Biological prosthetic valves are an alternative, but they have their own 
disadvantages, the most important of which is their high deterioration rate, 
especially in young patients and during pregnancy, inevitably leading to re-
operation [3]. 
        Both types of valves share another complication: prosthesis-patient mismatch 
(PPM). PPM is present when the effective orifice area (EOA) of the inserted 
prosthetic valve is too small in relation to body size. In adults with acquired heart 
disease, PPM is associated with increased morbidity and mortality [4]. The 
prevalence of PPM is probably high in adult patients with CHD, both with biological 
and with mechanical valves, because of somatic growth of patients after 
implantation of a small valve during childhood. A few small series have 
investigated mid- and long-term complications of prosthetic valves including PPM 
in children [5,6]. However, the prevalence of PPM and its consequences in adult 
patients with CHD are unknown. 
        Adult patients with CHD and a prosthetic valve differ from patients with 
acquired valve disease in terms of age, lifestyle and underlying disease. 
Additionally, the prevalence of tricuspid and pulmonary prosthetic valves is higher 
in adult patients with CHD. These differences may lead to a different outcome in 
terms of functional capacity and quality of life as well as to a distinct spectrum of 
long-term complications associated with prosthetic valves. However, the influence 
of prosthetic valves on quality of life and functional outcome in adult patients with 
CHD has not been studied, and data on long-term complications are scarce [7]. We 
intend to study these issues in an adult population with CHD and prosthetic valves. 
In this article we introduce the study design and describe the rationale of the 
‘Functional outcome and quality of life in adult patients with congenital heart 



























The primary objective of this multicentre cross-sectional observational study is to 
investigate the relationship between characteristics of valve prostheses (type, size, 
location) and functional outcome as well as quality of life in adult patients with 
CHD (objective 1). The secondary objectives of this study are to investigate the 
prevalence and predictors of PPM (objective 2) and the incidence of prosthesis-
related complications (objective 3) in an adult CHD population. 
 
Study population 
Inclusion and exclusion criteria for objectives 1, 2 and 3 are shown in Table 1. All 
patients in the Dutch national CONCOR (‘CONgenital CORvitia’) database with 
valve prostheses (homografts, heterografts and mechanical valves) are eligible to 
participate in this study. Of the 900 identified patients, 702 were eligible for 
prospective investigation; by 15 February 2012, 406 of these patients with 424 
valves were included in the PROSTAVA study (Fig. 1). 
 
 
Table 1 Inclusion and exclusion criteria PROSTAVA 
Inclusion criteria  Exclusion criteria 
All objectives All objectives 
Included in the CONCOR database Patient aged < 18 years 
Prosthetic valve  
  
Objectives 1, 2 Objective 1, 2 
Patients able to understand the study procedures  Pregnant or < 3 months after pregnancy 
Patients willing to provide informed consent Inability to complete QoL questionnaire 
 
Inability to perform cardiopulmonary 
aerobic capacity testing 





Characteristics of valve prostheses (type, size and location) will be obtained from 
the medical records and from echocardiographic examination. For the evaluation 
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Figure 1. Prosthetic valves 
included in the 
prospective part of the 
study by 15 February 
2012. AVR = aortic valve 
replacement, PVR = 
pulmonary valve 
replacement, MVR = 
mitral valve replacement, 







of functional outcome and quality of life, cardiopulmonary aerobic capacity testing 
(CACT), New York Heart Association functional class and the SF-36 quality of life 
questionnaire will be used as primary outcome measures. Confounders which may 
influence the quality of life and functional outcome, such as ventricular function, 
native valve dysfunction and rhythm disorders, will be recorded using 
echocardiography, magnetic resonance imaging (MRI) and 24-hour Holter 
recording. 
Objective 2 
To investigate the prevalence and degree of PPM, echocardiography will be used 
to measure the EOA and calculate the indexed EOA (iEOA = EOA/Body Surface 
Area). Consequences of PPM including the presence and degree of ventricular 
hypertrophy, ventricular and atrial volumes, and pulmonary pressures will be 
measured with MRI and/or echocardiography. Possible predictors of PPM will be 
identified from the medical records, such as underlying heart disease, type of 
cardiac surgery, type and size of valve prosthesis and age at implantation.  
Objective 3 
The inventory of the patient’s past medical history and present medical status 
(including current medical history and physical examination) will be used to record 
the incidence of prosthesis-related complications. Published guidelines will be 
used for the registration of complications [8]. To ensure completeness of data 
collection a patient interview will be used to check if any data were missed by 
studying the medical files; however, data that can not be verified from medical 






























AVR Bentall Ross PVR MVR TVR
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        Laboratory evaluations will be performed to obtain information on heart 
failure and haemolysis. To detect rhythm disorders, ventricular hypertrophy and 
intraventricular conduction delays, electrocardiogram and 24-hour Holter 
monitoring will be used. Ventricular volumes, mass and function and prosthetic 
valve function will be assessed using echocardiography and MRI.  
 
Cardiopulmonary aerobic capacity testing 
The parameters to be recorded are: expected and achieved VO2max, respiratory 
quotient, anaerobic threshold, blood pressure at rest and during exercise, and 
heart rate at rest and during exercise.  
 
Quality of life questionnaire 
Quality of life will be assessed using the short-form 36 health survey 
questionnaire. This questionnaire consists of 36 items to measure health and 
quality of life using a multi-item scale for eight different aspects: physical 
functioning, role of limitations due to physical problems, role of limitations due to 
emotional problems, social functioning, mental health, pain, energy/vitality and 
general health. Furthermore, there is a single item on changes in respondents’ 
health over the past year. 
 
Echocardiography 
Two-dimensional echocardiography will be performed according to current 
guidelines to assess the function of prosthetic and native valves, to quantify 
chamber dimensions and left ventricular mass, and to assess chamber function. 
Pulmonary artery systolic pressure will be estimated and disease-specific 
evaluation performed. The EOA will be determined by the continuity equation 
using continuous and pulsed wave Doppler. For prosthetic valves, moderate PPM 









. For the mitral and tricuspid 











Magnetic resonance imaging 
Systemic and pulmonary ventricular function, volume and mass will be determined 
with a steady-state free precession cine sequence in the short-axis plane. Flow 
dynamics, including the regurgitation fraction of the aortic and pulmonary valve, 
will be assessed by using velocity-encoded MR imaging distal to the prosthetic 
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valve. It is expected that approximately 25% of the patients will have a 
contraindication for MRI (i.e. pacemaker).  
 
Statistical and ethical considerations 
Sample size Because this is an explorative study in a population where the 
prevalence of both valve characteristics (e.g. PPM) and the values for outcome 
measures are yet unknown, an appropriate sample calculation is not possible. 
However, the populations we expect to include are sufficiently large for all valve 
locations; therefore, meaningful outcomes can be expected. 
 
Statistical analysis 
Continuous variables will be expressed as mean and standard deviation when 
normally distributed or as median with interquartile ranges in case of non-normal 
distribution. Categorical variables will be presented as absolute numbers and 
percentages. 
        Groups will be compared by using independent Student’s t-test for normally 
distributed continuous variables. Mann-Whitney U test will be used for 
comparisons of non-normally distributed continuous variables, and 
2
 test or 
Fisher’s exact test for comparison of categorical variables. Univariate and 
multivariate logistic regression analysis will be performed to identify independent 
predictors for main outcome measures. All statistical analyses will be performed 
using the statistical software package SPSS version 16.0 or higher (SPSS Inc., 
Chicago, IL). All statistical tests are two-tailed and a P-value of <.05 is considered 
statistically significant.  
 
Ethical considerations 
The PROSTAVA study has been approved by the Medical Ethics Committee of all 
the participating hospitals (METc2009/270; NL29965.042.09). The study will be 
conducted in accordance with the Helsinki Declaration. Subjects will be asked to 
participate and sign a written informed consent form after having received written 



























In the proposed PROSTAVA study, we will assess the implications of prosthetic 
valves in adult patients with CHD. We will have the opportunity to relate 
prosthetic valve characteristics to functional outcome and quality of life in a 
unique large-scale patient cohort. In addition we will investigate the incidence of 
complications related to prosthetic valve type, size and location in this adult 
population with CHD. 
 
Valve type: biological or mechanical valve prosthesis 
In children and young adults, biological valves are often implanted to avoid the 
disadvantages of oral anticoagulation therapy. The rate of structural valve 
degeneration is, however, high at young age. Structural valve deterioration results 
in progressive prosthesis dysfunction which will impair functional capacity and 
which ultimately leads to valve replacement. The influence of the amount and 
prospect of re-operations on quality of life in patients with CHD has only been 
studied in a relatively small population and seems to be limited [11]. However, 
parameters reflecting functional status are associated with satisfaction with life 
and perceived health [12]. Therefore we expect that structural valve deterioration 
in adult patients with CHD will influence quality of life through its impact on 
functional outcome, which we will elucidate in the PROSTAVA study. 
        Structural valve deterioration and re-operations can be avoided by use of 
mechanical prostheses. The risk of thromboembolic complications warrants the 
need for anticoagulation therapy resulting in an increased risk of bleeding 
complications. The cumulative risk of bleeding complications during life may well 
be high in young adults with CHD because of their long life expectancy after valve 
replacement. The risk of bleeding complications may be increased by the active 
lifestyle of many young adult patients with CHD. Frequent international 
normalised ratio (INR) controls are needed with anticoagulant therapy and 
patients are prevented from participating in risky sports activities. Poor 
compliance with warfarin therapy, which is not uncommon in adolescents, can 
increase the risk of thromboembolic complications. Pregnancy in women with 
mechanical valves bears the risk of foetal loss and embryopathy when oral 
anticoagulants are continued throughout pregnancy, while substitution with 
heparin increases the risk of thromboembolic complications [13,14]. Therefore, 
the impact of anticoagulation therapy is probably high in this young population. 
Our study will provide insight into the incidence and predictors of biological and 
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mechanical prosthesis-related complications in adult patients with CHD as well as 
the consequences for quality of life and functional outcome. 
 
Valve size: the impact of PPM 
When valve replacement is necessary in childhood, implantation of an adult-sized 
prosthetic valve is often not possible. With somatic growth in children, the iEOA 
decreases steadily until they reach adulthood. Therefore we expect that in our 
study population the prevalence of PPM will be high. 
        A few small series have investigated PPM in children [15]. However, in adult 
patients with CHD the prevalence and consequences of PPM are unknown. In 
patients with acquired valve disease, aortic PPM is associated with less 
improvement in symptoms and exercise capacity, less regression of left ventricular 
hypertrophy, more cardiac events and higher mortality [4,9,16]. Mitral PPM is 
associated with recurrence of congestive heart failure, pulmonary hypertension 
and decreased survival [10]. We expect that PPM in adult patients with CHD will 
further diminish the already compromised ventricular function and exercise 
capacity. This reduction in exercise capacity may negatively influence quality of life 
by limiting these patients in their daily activities. Our study will provide a 
comprehensive database with a long follow-up to present us with useful 
information on the incidence, predictors and consequences of PPM in adult CHD 
patients.  
 
Valve location: right-sided versus left-sided prostheses 
Prevalence of tricuspid and pulmonary prosthetic valves is relatively high in adult 
patients with CHD compared with patients with acquired valve disease. In right-
sided mechanical prostheses thromboembolic risk is presumed to be higher 
compared with left-sided mechanical prostheses due to lower pressures and flow 
velocities in the right heart. Therefore, biological valves are the preferred valve 
type in the tricuspid and pulmonary position in most centres. Several recent 
studies have reported satisfactory results in pulmonary mechanical prostheses 
with aggressive anticoagulation, INR 3.0-4.5 [17,18]. However, data concerning 
long-term survival, and thromboembolic and bleeding complications are still 
limited. Available studies are small and the only large study with more than 30 
patients has a short median follow-up of only 2 years. The proposed study gives 
the possibility to compare complications of pulmonary mechanical valves in a 
relatively large cohort (54 patients) and a cohort of patients with biological valves, 


























A limitation of our study is the presence of multiple confounding factors such as 
the heterogeneity of patients with CHD, multiple types and locations of prosthetic 
valves and differences in ventricular function. Regression analysis will partially 
overcome this limitation. As patients who are not able to complete the CACT and 
quality of life questionnaire will be excluded from the prospective study, the study 
population will not entirely representative for adult patients with CHD and a 
prosthetic valve. 
        Another limitation comes with the use of the CONCOR database. This 
database started including patients with CHD in 2001. Patients who died before 




The PROSTAVA study is the first study to investigate the influence of prosthetic 
valve characteristics on functional outcome and quality of life in adult congenital 
heart disease patients. Our results may influence the choice of valve prosthesis, 
the indication for more extensive surgery and the indication for re-operation in 




Magnetic resonance imaging 
MRI is performed at least 6 months after valve implantation. Systemic and 
pulmonary ventricular function, volume and mass are determined with a steady-
state free precession cine sequence in the short-axis plane for the left ventricle. 
Flow dynamics, including regurgitation fraction of the aortic and pulmonary valve, 
are assessed by using velocity-encoded MR imaging distal to the prosthetic valve. 
No contrast agent is given. Function and flow are quantitatively analyzed by the 
department of Radiology of the University Medical Center of Groningen using a 
commercial software package (QMass version, Medis, Leiden, The Netherlands). 
The end-systolic and end-diastolic frames were selected by visual assessment 
independently for the left and right ventricle. The basal slice was selected with aid 
of long-axis cine view images. The basal slice of the left ventricle was defined as 
the most basal slice surrounded for at least 50% by the left ventricular 
myocardium. When the pulmonary valve was visible in the right ventricular basal 
slice, only the portion of the right ventricular outflow tract below the level of the 
pulmonary valve was included. The inflow part of the right ventricle was included 
in the right ventricular volume. The right ventricular inflow part was distinguished 
from the right atrium by recognizing the trabeculated and thick right ventricular 
wall compared to the thin right atrial wall. Contours were drawn manually by 
tracing the endocardial and epicardial borders in every slice in end-systole and 
end-diastole. Contour tracing was aided by reviewing the multiple phase scans in 
the movie mode. 
 
Discussion 
We expect PPM to be uncommon in pulmonary prosthetic valves as most of these 
patients received relatively large prosthetic valves in their dilated right ventricular 
outflow tracts. However, almost all pulmonary and tricuspid valve replacements 
are performed using biological prosthetic valves. The main complication of this 
valve type is structural valve deterioration resulting in a combination of stenosis 
and regurgitation. Mechanical pulmonary valve prostheses show no substantial 
increase in gradient and regurgitation with time. Three years after pulmonary 
valve replacement, mechanical valve prostheses have a superior hemodynamic 
performance compared to homografts. With our study we can investigate whether 
patients with mechanical valve prosthesis also benefit in terms of right and left 
ventricular volumes and function, exercise capacity and quality of life. 
























replacement that combined right ventricular outflow tract obstruction and 
pulmonary regurgitation results in smaller right ventricular volumes and better 
ejection fraction compared to patients with isolated pulmonary regurgitation. We 
can investigate whether similar findings are present in patients with biological 
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The introduction of palliative surgery led to an increased number of patients with 
complex congenital heart disease surviving into adulthood. At the same time 
sophisticated invasive and non-invasive imaging modalities became available. 
However, most patients develop long-term complications involving the right 
ventricle. The combination of a large group of patients with a dysfunctional right 
ventricle and new imaging modalities boosted our understanding of anatomy, 
physiology and pathophysiology of the right heart as well as improved care for 
patients with right sided congenital heart disease. Nowadays, imaging is 
considered a cornerstone in the follow-up of patients with congenital heart 
disease. Cardiac magnetic resonance is considered the gold standard for 
evaluation of cardiac volumes and function. Measurements of right ventricular 
volumes and function do not rely on assumptions of geometry but uses slice 
summation to calculate volumes, which are highly accurate and reproducible. 
However, knowledge on the used methodology and patient characteristics is 
essential for interpreting right ventricular volume measurements. 
        In Chapter 1 a general introduction on the right ventricle is provided with a 
focus on imaging. Chapter 2 evaluated the influence of independent selection of 
the end-systolic and end-diastolic frame for the right and left ventricle on cardiac 
magnetic resonance derived right ventricular volume measurements in patients 
with tetralogy of Fallot. Dyssynchrony resulting from a right bundle branch block in 
these patients significantly extends duration of right ventricular contraction and 
delays timing of right ventricular end-systole compared to the left ventricle. 
Additionally, timing of right ventricular ejection and end-diastole may be delayed 
in patients with tetralogy of Fallot. In some centers all right ventricular volumes 
are routinely measured in the left ventricular end-systolic and end-diastolic frame. 
We examined to what extent this result in a misrepresentation of right ventricular 
volumes. Right ventricular end-systolic volume using the right ventricular end-
systolic instead of left ventricular end-systolic frame was smaller. Using the right 
ventricular end-systolic and end-diastolic frame hardly affected right ventricular 
end-diastolic volumes, while increasing the ejection fraction. QRS duration 
correlated positively with the changes in the right ventricular end-systolic volume 
and right ventricular ejection fraction when using the right ventricular instead of 
the left ventricular end-systolic and end-diastolic frame. We conclude that for 
clinical decision making in patients with tetralogy of Fallot and a right bundle 
branch block, right ventricular volumes should be measured in the end-systolic 
frame of the right ventricular and not of the left ventricle. 
        Current clinical practice is to include papillary muscles and trabeculae in the 
blood volume which introduces a bias in the measured volumes and ejection 
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fraction. This bias is generally accepted, as manually excluding the papillary 
muscles by drawing non-convex endocardial contours is even more time 
consuming and has demonstrated a higher intra- and inter-observer variability. An 
automated segmentation of blood and muscle could not only provide faster and 
more objective analysis, but may also yield more accurate estimations of cardiac 
volumes and function than the manual method. In Chapter 3 we validated a novel 
semi-automatic threshold-based segmentation algorithm in an anthropomorphic 
heart phantom, and the left ventricle of twelve subjects with normal cardiac 
function. The semi-automatic threshold-based segmentation software we 
developed classified voxels within the epicardial contour as either blood or muscle 
according to their signal intensity, taking into account spatial variations in signal 
intensity. We showed that this semi-automatic method could exclude left 
ventricular endoluminal muscular structures from the blood volume with 
significantly improved intra- and inter-observer variabilities in function 
measurements compared to the conventional, manual method, which includes 
endoluminal structures in the blood volume.  
        Chapter 3 was limited to the left ventricle. Therefore, we used the same 
software in Chapter 4 to measure trabecular volume of the right ventricular in 
adult patients with repaired tetralogy of Fallot. The main complication after repair 
for tetralogy of Fallot is right ventricular volume overload due to pulmonary 
regurgitation. Furthermore, many patients have some amount of pressure 
overload caused by residual outflow tract obstruction, stenosis of a pulmonary 
artery branch or stenosis of a valve prosthesis. These residual lesions result in right 
ventricular dilatation and hypertrophy. Consensus is lacking on whether to 
consider trabeculae and papillary muscles as part of measured right ventricular 
volumes. In healthy subjects and patients without congenital heart disease, the 
influence of trabeculae and papillary muscle on right ventricular volumes is too 
small to be of clinical importance. However, in patients with repaired tetralogy of 
Fallot the increase in papillary muscles and trabeculae can be large. As timing of 
re-operations is guided by right ventricular volumes, the effect of including 
papillary muscles and trabeculae in the right ventricular blood volume is of clinical 
importance. We showed that the semi-automatic threshold-based segmentation 
software provided a reproducible method to differentiate right ventricular 
myocardium from blood. Compared to including papillary muscle and trabeculae 
from the right ventricular blood volume, exclusion of the papillary muscle and 
trabeculae in the right ventricular blood volume resulted in clinical significantly 
decreased end-systolic and end-diastolic volumes and increased ejection fraction 
















        In Chapter 5 the impact of trabeculae and papillary muscles on right 
ventricular volumes and function was assessed in different patient groups with 
pressure overloaded right ventricles using the same software as in Chapters 3 and 
4. As already shown in Chapter 4, exclusion of trabeculae and papillary muscles 
from the right ventricular blood volume result in significant and potentially 
clinically relevant differences in right ventricular volumes, right ventricular ejection 
fraction and right ventricular mass. Furthermore the impact of trabeculae on right 
ventricular volumes and function differed markedly depending on the underlying 
etiology of right ventricular pressure overload. 
        Chapter 6 evaluated the effects of right ventricular outflow tract obstruction 
on exercise capacity, right ventricular volumes, function and mass in adult patients 
with tetralogy of Fallot and volume overload due to pulmonary regurgitation. 
Recent studies demonstrated that patients with tetralogy of Fallot and combined 
pulmonary regurgitation and right ventricular outflow tract obstruction have 
smaller right ventricular volumes and higher ejection fraction compared to 
patients with isolated pulmonary regurgitation. New York Heart Association 
functional class was not different between both patient groups. However, since 
functional class is known to be poorly correlated with objective exercise capacity, 
it remained unclear what the effect of right ventricular outflow tract obstruction is 
on exercise capacity. We were the first to show that patients with combined right 
ventricular outflow tract obstruction and pulmonary regurgitation have reduced 
exercise capacity despite more favourable right ventricular volumes at rest 
compared to patients without right ventricular outflow tract obstruction. 
Furthermore, peak pressure gradient across the right ventricular outflow tract was 
the only independent predictor of percentage of predicted peak oxygen uptake. 
Therefore, exercise testing as well as cardiac magnetic resonance imaging should 
be interpreted in conjunction with the presence of right ventricular outflow tract 
obstruction. 
        Due to the improved survival of children with congenital heart disease, the 
number of adults with congenital heart disease has increased and adult patients 
with congenital heart disease now outnumber children. Many of these patients 
have prosthetic valves as part of their treatment. The influence of prosthetic 
valves on quality of life and functional outcome in adult patients with congenital 
heart disease has not been studied, and data on long-term complications are 
scarce. Therefore, the multicenter cross-sectional observational study described in 
Chapter 7 will assess the implications of prosthetic valves in adult patients with 




Imaging is becoming more and more important in medicine, especially in the care 
for grown-ups with congenital heart disease. The main purpose of this thesis on 
imaging of the right ventricle is to improve care for patients with congenital heart 
disease as decisions to re-operate or initiate medical therapy are increasingly 
based on cardiac volumes and function. In the (near) future budgets for research 
are more likely to decrease than increase. Therefore, improving care for patients 
with congenital heart disease will become more dependent on retrospective 
studies. To make these future retrospective studies a success, standardisation in 
clinical management is the key. Currently, in many patients echocardiography, 
magnetic resonance imaging, exercise testing and biomarkers are not performed 
at regular intervals or combined with each other. Therefore, to boost the number 
and size of future retrospective studies we should put more effort in developing 
protocols for examining patients with congenital heart disease and especially in 
the compliance to these protocols. 
        Important in this setting is also a thorough description of the used 
methodology (e.g. inclusion or exclusion of trabeculae) as methods change during 
time. We showed that methodology can have a profound impact on the 
measurements of right ventricular volumes and function. Interpretation of studies 
which used different methodologies is difficult or even impossible when the used 
methodology is not clearly described. To guarantee high accuracy and 
reproducibility of cardiac volume and function measurements, post-processing 
should be easy and uniform. Independent selection of the end-systolic phase can 
be implemented in clinical practice with great ease. Furthermore, the semi-
automatic threshold-based software described in this thesis is currently being 
implemented in commercial software. Widespread application of this software 
may be a step forward in the direction of achieving uniformity of right ventricular 
volume measurements, which would be of great importance for research and 






















De afgelopen decennia zijn er twee belangrijke ontwikkelen geweest die nog 
steeds gaande zijn. Door nieuwe operatietechnieken en verbeterde zorg op de 
kinder en volwassen leeftijd is de levensverwachting van patiënten met een 
complexe aangeboren hartafwijking sterk toegenomen. Daarnaast zijn er nieuwe 
invasieve en non-invasieve methoden ontwikkeld om het hart af te beelden. Bij 
patiënten met een aangeboren hartafwijking wordt hier veelvuldig gebruik van 
gemaakt aangezien veel patiënten op volwassen leeftijd complicaties krijgen van 
de rechter kamer van het hart. De combinatie van een grote groep patiënten met 
problemen van de rechter kamer en nieuwe beeldvormende technieken heeft 
geleid tot een sterke toename in kennis over anatomie, fysiologie en 
pathofysiologie van de rechter kamer alsmede verbeterde zorg voor patiënten met 
rechtszijdige aangeboren hartafwijkingen. Tegenwoordig is beeldvorming een van 
de hoekstenen in de zorg voor patiënten met een aangeboren hartafwijking. MRI 
van het hart wordt hierbij beschouwd als de gouden standaard voor het bepalen 
van de hartvolumes en functie. MRI is erg nauwkeurig en reproduceerbaar doordat 
er geen aannames worden gedaan over de vorm van de rechterkamer maar 
gebruik maakt van ‘slice summation’, dat wil zeggen dat hartvolumes van iedere 
gescande plak bij elkaar worden opgeteld. Van belang is hierbij dat men weet hoe 
er gemeten is aangezien de meetmethode van grote invloed kan zijn op de 
gemeten volumes. Daarnaast is bij de interpretatie van de gevonden volumes 
informatie over de patiëntenkarakteristieken onmisbaar.  
        In Hoofdstuk 1 word een algemene introductie gegeven over de rechter 
kamer met een focus op de beeldvorming. In Hoofdstuk 2 hebben we middels MRI 
de volumes van de rechter hartkamer gemeten in de eind-systolische en eind-
diastolische fase van zowel de rechter als linker kamer bij volwassen patiënten met 
een gecorrigeerde tetralogie van Fallot. Vrijwel al deze patiënten hebben een 
rechter bundeltakblok waardoor de rechter kamer langzamer samentrekt en het 
moment van de eind-systole later valt vergeleken met de linker kamer. Daarnaast 
valt mogelijk ook de eind-diastolische fase later. In sommige ziekenhuizen is het de 
gewoonte om alle rechter kamervolumes te meten in de eind-systolische en eind-
diastolische fase van de linker kamer. Wij laten zien dat rechter kamer volumes 
gemeten in de eind-systolische en einddiastolische fase van de rechter kamer in 
plaats van de linker eind-systolische en eind-diastolische fase resulteerde in 
kleinere rechter kamer eind-systolische volumes, hogere ejectie fracties en vrijwel 
geen verschil in eind-diastolische volumes. Bij een toename in QRS duur namen 
deze verschillen toe voor wat betreft eind-systolisch volume en ejectie fractie. Wij 
concluderen dat het klinisch relevant kan zijn om bij patiënten met een tetralogie 
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van Fallot en een rechter bundeltakblok, de rechter kamervolumes te meten in de 
eind-systolische fase van de rechter kamer en niet die van de linker kamer. 
        Vaak worden de papillairspieren en trabeculae tot het bloedvolume gerekend 
bij het meten van hartvolumes middels MRI waardoor er te grote bloedvolumes 
worden gemeten. Deze meetfout wordt over het algemeen geaccepteerd omdat 
handmatig excluderen van alle papillairspieren en trabekels door het tekenen van 
extra contouren zeer veel tijd kost en slecht te reproduceren is. Semi-
automatische segmentatie van bloed en spier zou de hartvolumes niet alleen 
sneller en objectiever kunnen bepalen, maar ook nog eens accurater kunnen zijn 
dan handmatig de volumes te bepalen. In Hoofdstuk 3 valideren we een nieuwe 
semi-automatische methode in een hartfantoom en twaalf linker kamers bij 
personen met een normale hartfunctie. Het algoritme classificeert voxels binnen 
de epicardiale hartcontour als bloed of als spier afhankelijk van de signaal 
intensiteit waarbij rekening wordt gehouden met spatiële variaties in de 
signaalintensiteit. Wij laten zien dat deze semi-automatische methode trabekels 
en papillairspieren uit het bloedvolume kan excluderen met een significant 
verbeterde intra- en interobserver reproduceerbaarheid vergeleken met de 
conventionele manuele methode waarbij deze structuren tot het bloedvolume 
worden gerekend.  
        Hoofdstuk 3 beperkte zich tot de linker kamer. Daarom hebben we in 
Hoofdstuk 4 dezelfde software gebruikt om het volume van trabekels en 
papillairspieren te meten in de rechter kamer van volwassen patiënten met een 
gecorrigeerde tetralogie van Fallot. De belangrijkste complicatie na correctie van 
een tetralogie van Falot is rechter kamer volumeoverbelasting door 
pulmonaalklepinsufficiëntie. Daarnaast hebben veel patiënten enige mate van 
drukoverbelasting door een resterende uitstroombaan obstructie, stenose van een 
pulmonalistak of stenose van een kunstklep. Deze resterende afwijkingen 
resulteren in rechter ventrikel dilatatie en hypertrofie. Er is geen consensus bij het 
meten van de rechter kamer of de trabekels en papillairspeieren gerekend moeten 
worden tot de ventrikel bloedvolumes of spiermassa. Bij gezonde vrijwilligers en 
patiënten zonder aangeboren hartafwijking is de invloed van trabekels en 
papillairspieren  op de gemeten rechter ventrikel volumes te klein om van klinisch 
belang te zijn. Echter, bij patiënten met een aangeboren hartafwijking kan de 
toename in trabekels en papillairspieren groot zijn. Aangezien het moment van 
opereren gedeeltelijk bepaald wordt door de gemeten rechter kamervolumes kan 
het van klinisch belang zijn om te weten wat het effect is van papillairspieren en 
trabekels te includeren in de gemeten bloedvolumes. Wij laten zien dat de semi-


























scheiden. Exclusie vergeleken met inclusie van papillairspieren en trabekels in het 
rechter kamervolume resulteert in significant kleinere eind-systolische en eind-
diastolische volumes en grotere rechter kamer massa en ejectiefractie welke 
klinisch significant zouden kunnen zijn. 
        In Hoofdstuk 5 wordt met behulp van dezelfde software als in Hoofdstuk 3 en 
4 de invloed van inclusie of exclusie van trabekels en papillairspieren op rechter 
kamer volumes en functie onderzocht bij groepen patiënten met een verschillende 
mate van drukoverbelasting van de rechter kamer. Net als bij de patiënten in 
hoofdstuk 4, resulteerde exclusie van trabekels en papillairspieren tot significante 
en mogelijk klinische relevante verschillen in rechter ventrikel volumes, 
ejectiefractie en massa. De invloed van trabekels op de rechter kamer metingen 
waren sterk afhankelijk van het onderliggend ziektebeeld. 
        In Hoofdstuk 6 wordt het effect bekeken van rechter kamer 
uitstroombaanobstructie op inspanningsvermogen, rechter kamervolumes, functie 
en massa bij volwassen patiënten met een gecorrigeerde tetralogie van Fallot en 
volumeoverbelasting door pulmonalisklepinsufficientie. Recente onderzoeken 
hebben laten zien dat patiënten met een gecorrigeerde tetralogie van Fallot en 
gecombineerde pulmonalisinsufficientie en rechter kamer uitstroombaan 
obstructie kleinere rechter kamervolumes en een hogere ejectie fractie hebben 
vergeleken met patiënten met geïsoleerde pulmonalisinsufficientie. New York 
Heart Association functionele klasse was niet verschillend tussen beide 
patiëntengroepen. Van deze functionele klasse is echter bekend dat er een slechte 
correlatie is met het objectief gemeten inspanningsvermogen. Daarom is het 
onduidelijk wat de invloed is van rechter ventrikel uitstroombaanobstructie op het 
inspanningsvermogen. Wij laten zien dat patiënten met een gecombineerde 
rechter ventrikel uitstroombaanobstructie en pulmonalisklepinsufficiëntie 
vergeleken met patiënten met een geïsoleerde pulmonalisklepinsufficientie een 
verminderd objectief bepaald inspanningsvermogen hebben ondanks betere 
rechter ventrikel volumes in rust. Daarnaast was de piekdrukgradient over de 
rechter uitstroombaan de enige onafhankelijke voorspeller van het percentage van 
voorspelde piek zuurstofopname. Daarom zou zowel inspanningsonderzoek als 
rechter kamer metingen geïnterpreteerd moeten worden met kennis over de 
aanwezigheid van een rechter kamer uitstroombaanobstructie. 
        Door de verbeterde overleving van kinderen met een aangeboren 
hartafwijking is het aantal volwassen patiënten met een aangeboren hartafwijking 
sterk toegenomen en is het aantal volwassen patiënten inmiddels groter dan het 
aantal kinderen. Veel van deze volwassen patiënten hebben een nieuwe hartklep 
gekregen als onderdeel van hun behandeling. De invloed van nieuwe hartkleppen 
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op kwaliteit van leven en inspanningsvermogen bij volwassen patiënten met een 
aangeboren hartafwijking is nog niet onderzocht, en gegevens over lange termijn 
complicaties zijn schaars. Daarom zal het multicenter cross sectionele 
observationele onderzoek beschreven in Hoofdstuk 7 de gevolgen van 
kunstkleppen onderzoeken in volwassen patiënten met een aangeboren 
hartafwijking. In dit proefschrift wordt de rol van beeldvorming van de rechter 
kamer in dit onderzoek uitgelicht.  
 
Toekomst 
Beeldvorming wordt steeds belangrijker in de geneeskunde, vooral bij het bepalen 
van het beleid bij volwassenen met een aangeboren hartafwijking. Het 
belangrijkste doel van dit proefschrift over beeldvorming van de rechter hartkamer 
is daarom ook het verbeteren van deze zorg aangezien het besluit te re-opereren 
of andere therapie te starten vaak gebaseerd wordt op metingen van het hart 
middels MRI. In de (nabije) toekomst is het waarschijnlijk dat financiering van 
onderzoek onder druk komt te staan. Daarom zal retrospectief onderzoek steeds 
belangrijker worden. Om ervoor te zorgen dat er in de toekomst goede 
retrospectieve onderzoeken gedaan kunnen worden is het nu al belangrijk om veel 
onderzoeken gestandaardiseerd uit te voeren. In de huidige praktijk is het vaak zo 
dat patiënten een echo hart, MRI hart, inspanningsonderzoek en biomarkers niet 
met een vaste regelmaat of gecombineerd worden uitgevoerd. Om het aantal en 
de grootte van toekomstige retrospectieve onderzoeken te bevorderen zouden we 
meer inspanningen moeten leveren om protocollen te ontwikkelen voor patiënten 
met een aangeboren hartafwijking en zich ook aan de protocollen te houden. 
        Belangrijk in deze setting is om de gebruikte methode nauwkeurig te 
beschrijven (b.v. inclusie of exclusie van trabekels) aangezien methodes 
veranderen gedurende de jaren. Interpretatie van onderzoeken die andere 
methodes hebben gebruikt is vaak moeilijk of zelfs onmogelijk wanneer het niet 
goed beschreven is. Om een hoge mate van nauwkeurigheid en 
reproduceerbaarheid te garanderen moet analyseren van de MRI beelden 
makkelijk en uniform zijn uit te voeren. Onafhankelijke selectie van de eind-
systolische plak is makkelijk te implementeren in de klinische praktijk. Daarnaast 
wordt de semi-automatische software die gebruikt is in dit proefschrift op moment 
van schrijven geïmplementeerd in reeds bestaande commercieel verkrijgbare 
software. Wijdverspreid gebruik van deze software kan een eerste stap zijn 
richting het uniform meten van rechter hartkamer volumes waardoor makkelijker 



































Vader worden, verhuizen, toetreden tot TR125, beginnen met de opleiding tot 
radioloog. Dit zijn allemaal gebeurtenissen die grote invloed hebben (gehad) op 
mijn leven de afgelopen jaren. Mijn promotietraject is nu ten einde en hoort ook in 
dit rijtje thuis. Maar dit proefschrift is niet alleen mijn verdienste. Zonder de 
bijdrage van velen was het nooit zover gekomen of waren de afgelopen jaren lang 
niet zo gezellig geweest. Een aantal personen wil ik graag in het bijzonder 
bedanken. 
 
Allereerst wil ik mijn promotor, Dirk Jan, bedanken. Hoewel mijn proefschrift 
uiteindelijk vrijwel geheel gericht is op de radiologische kant van mijn werk de 
afgelopen jaren waren jouw suggesties wat betreft de opbouw en boodschap van 
artikelen van onschatbare waarde. 
 
Tineke, mijn co-promotor, zonder jou was dit proefschrift zeker niet mogelijk 
geweest. Jouw enthousiasme en grote betrokkenheid hebben mij er mede van 
overtuigd om toch door te gaan met het onderzoek nadat ik eigenlijk besloten had 
te stoppen. Daarnaast zit je altijd barstensvol goede onderzoeksideeen waarvan 
we er vele hebben uitgewerkt. 
 
Els, mijn tweede co-promotor, ik ben je dankbaar dat ik samen met Ymkje de 
PROSTAVA studie heb mogen uitvoeren. Ik heb heel veel van je geleerd. 
 
Joost, hoewel je niet mijn co-promotor was, was je samen met Els de tweede 
begeleider van PROSTAVA. Mede dankzij jouw inzet en gedrevenheid hebben we 
een groot aantal patiënten kunnen includeren. 
 
Petra en Martijn, mijn kamergenoten, wil ik graag bedanken voor de gezellige tijd 
die we hebben gehad. Petra, zonder jou had ik niet kunnen promoveren. Jij bent 
een keiharde werker die mij altijd met raad en daad terzijde stond als ik ergens 
niet uit kwam. Daarnaast stel ik jouw oprechtheid en persoonlijke interesse erg op 
prijs. Martijn, wat hebben wij een plezier beleefd aan het spelen van Bomberman 
in de pauze. Maar het meest heb ik nog genoten van ‘Promoveren in een 
gekkenhuis’ dat wij samen gemaakt hebben voor Petra. Daarvan heb ik nog wel 
het meest geleerd dat je samen meer bereikt dan in je eentje. 
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Ymkje, mijn PROSTAVA maatje, wil ik graag bedanken voor de vele gezellige en 
nuttige momenten. Ik ben blij dat ik samen met jou dit project heb mogen doen. 
 
Iedereen op de researchafdeling van de radiologie bedanken voor de prettige sfeer 
en de samenwerking. Karolien wil ik met name bedanken voor de samenwerking 
aan de artikelen over semi-automatische software. Martijn van Swieten, bedankt 
voor het doen van vele inter-observermetingen. Stella, als researchcoordinator 
ben jij onmisbaar voor iedereen die onderzoek doet bij de radiologie. Je kunt goed 
luisteren en geeft praktische adviezen wanneer nodig. Hoewel mijn vaste werkplek 
op de radiologie was wil ik ook graag de onderzoekers op de cardioresearch 
bedanken. Als ik er was, was het altijd gezellig. De secretaresses van de 
cardiologie, Alma en Audrey, wil ik graag bedanken voor alle hulp gedurende mijn 
promotietraject. Anna en Philemon, de studenten van Ymkje en mij, zonder jullie 
was de data nooit op tijd binnen geweest. De segmentatie methode is ontwikkeld 
door Medis. Daarom wil ik in het bijzonder Kees bedanken voor het schrijven van 
de software. David, ik vond het altijd erg leuk om te zien hoe enthousiast jij bezig 
was met het verbeteren van jullie producten en dat ik veel van mijn input ook 
terug zag in nieuwe versies. Alle co-auteurs van mijn artikelen wil ik graag 
bedanken voor hun bijdrage aan dit proefschrift. Graag wil ik ook alle mensen 
bedanken in de centra waar ik vanwege de PROSTAVA studie ben geweest. Mieke 
wil ik in het bijzonder bedanken, jij hebt mij veel werk uit handen genomen in 
Utrecht. 
 
Graag wil ik ook alle andere die ik nog niet genoemd heb, maar wel op de één of 
andere manier betrokken zijn geweest bij dit proefschrift. 
 
Lieve Gienke, bedankt voor je eindeloze liefde, begrip en support. Ik weet niet wat 
ik zonder jou zou moeten. Jochem en Stijn, jullie doen mij beseffen wat echt 
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